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ii 
Of central importance to the s1tUdy of heme proteins are the effects imposed by axial 
ligand(s) on the heme structure and, therefore, on the overall activity of the protein. In 
this study, we confirm and extend the spectroscopic characterization of a mutated sperm 
whale myoglobin in which the proximal Histidine is replaced with a Tyrosine residue 
(MbH93Y). The MbH93Y, as well as wild-type sperm whale myoglobin and horse 
erythrocyte catalase (HBC), was pwified and characterized by optical absorption and x-ray 
absorption (XAS) spectroscopies. Optical absorption spectra of HEC and the 
metmyoglobin, cyanometmyoglobin, reduced, oxy, and carbon-monoxy forms of both 
sperm whale myoglobin (SWMb) and MbH93Y were identical to previously reported 
values within the respective errors:. Extended x-ray absorption fine structure (EXAFS) 
studies revealed that the proximal bond length in MbH93Y was 2.13 ± 0.03 A, compared 
to 2.14 ± 0.02 A for sperm whale metmyoglobin and 1.90 ± 0.02 A for catalase. 
iii 
Additionally, the sixth coordination site normally occupied in wild type sperm whale 
metmyoglobin and in catalase at low temperatures was vacant in MbH93Y, a result 
corroborated by the optical absorption spectra and cyanogen bromide modification of the 
distal histidine. Measurements were also made on the cyanide complexes of the three 
proteins as well, among which, (i) 1the average iron-to-pyrrole nitrogen bond distance for 
MbH93Y-CN was 1.96 ± 0.015 A compared to 2.00 ± 0.015 A for WT SWMb-CN and 
HEC-CN and (ii) the proximal bond length in MbH93Y-CN was 2.07 ± 0.02 A, while that 
of WT SWMb-CN was 2.10 ± 0.02 A and that of HEC-CN was found to be 2.12 ± 0.02 
A. Further, upon exposure to 2-molar equivalents of hydrogen peroxide, sperm whale 
myoglobin formed a Compound II -like spectrum, while the Soret absorbance of MbH93Y 
was rapidly, significantly, and imeversibly decreased. Furthermore, the dissociation 
constants for CN- binding to MbH93Y were found to be, on average, approximately three 
orders of magnitude higher than those of wild-type sperm whale myoglobin and are 
consistent with the many-fold highier cyanide binding kinetics for wild type, relative to 
the mutant protein. Finally, the PK. of the mutant was found to be more than three orders 
of magnitude higher than that of the native protein. Explanations focusing on probable 
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The study of structure-function relationships has, for a long time, been a dominant 
theme in heme protein chemistry. . Indeed, one of the most obvious approaches to 
tackle this problem has been through the use of various ligands or substrates to probe 
the active sites of the respective proteins (e.g., for some of the earlier work on 
myoglobin and hemoglobin, see Antonini and Brunori, 1971). In the case of 
myoglobin, virtually every aspect of this protein has been examined in this way, since 
from a structural point of view, myoglobin is among one of the simplest of heme 
proteins. The binding and releasilrig of diatomic molecules (e.g., CO, NO, CN·, OJ 
to and from myoglobin has physiological relevance and, depending on the pH 
(Shimada and Caughey, 1982; Ramsden and Spiro, 1989), either 0 2 (Potter et al., 
1987) or CO (Cheng and Schoenborn, 1991; Makinen et al., 1979; Shimada and 
Caughey, 1982; Moore et al., 1988; Balasubramanian et al., 1993a, b) binding 
culminates in discrete geometric conformations or a transient intermediate (Sato et al., 
1990) of the ligand-bound myoglobin. Furthermore, Bormett et al. (1992) found one 
covalent band and one ionic band iln the vibrational circular dichroism spectra of N3• -
bound elephant myoglobin, suggesting the presence of two conformational substates. 
In addition, the reaction pathway that the diatomic molecules follow in the heme 
pocket has been studied in detail (for a brief review, see Gibson, 1989). That is, the 
reaction pathway taken by these ligands has been painstakingly dissected using several 
approaches, including low- (Chanc1e et al., 1990) and room-temperature (Ramsden and 
2 
Spiro, 1989) kinetic studies. In addition, there are studies of the specific trajectory 
taken by the ligand, revealed by discrete geminate (recombining) states (Powers et al., 
1987), possibly due to the presence of many discrete conformational substates, each 
of which depends on the Ir2Hir 1 tautomerism and orientation of the distal His 
(Oldfield et al., 1992) and each of which possesses its own recombination rate constant 
(Siebrand et al., 1985). The variety of studies also include structural (Sage et al., 
1991b; Sage et al., 1992; Tian et all., 1993) and kinetic (Sage et al., 1991a; Sage et al., 
1992; Tian et al., 1993) interactions with the Fe-His bond at low pH. Finally, other 
studies have focused on the introduction of large ligands (e.g., n-butyl isocyanide) into 
the heme pocket (e.g., Gibson et al., 1986); thermodynamics of ligand binding (Sato 
et al., 1990a), and the effect of pn::ssure (Adachi and Morishima, 1989). 
The underlying implication of all these studies is that the protein matrix 
surrounding the active site is direcdy responsible for which ligands gain access to the 
heme pocket, how fast they do it, how tightly they bind, and how fast they dissociate. 
The structural and kinetic mechanisms of the binding of CN· to heme proteins has 
lately become a model upon which binding of other ligands such as 0 2 (Yamamoto et 
al., 1992) and CO (Emerson and LaMar, 1990b; Rajarathnam et al., 1992) are based. 
To this end, many studies have recently appeared using either 1H-1-dimensional 
(Lecomte et al., 1989; Satterlee and Erman, 1991; Keating et al., 1992; Rajarathnam 
et al., 1992; Yamamoto et al., 1992; Vyas et al., 1993) or 1H-2-dimensional (Emerson 
and LaMar, 1990a, b; Satterlee and Erman, 1991; Qin et al., 1992; Qin & LaMar, 
1992) NMR of cyanomet myoglobin in the buccal muscle of Aplysia mollusc (Qin et 
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al., 1992; Qin and LaMar, 1992), the stomach of Dolabel/a mollusc (Yamamoto et al., 
1992), skeletal muscle of sperm whale (Emerson and LaMar, 1990a, b), liver fluke 
Dicrocoelium (Lecomte et al., 1989), heme model compounds (Keating et al., 1992), 
and elephant (Vyas et al., 1993), as well as in other heme proteins, such as cyanide-
bound horseradish peroxidase (Thanabal et al., 1988; Banci et al., 1991; LaMar et al., 
1992) and cyanide-bound cytochrome c p~roxidase (Banci et al., 1991; Satterlee et al., 
1991; Satterlee and Erman, 1991). 
At least three of these heme proteins are known to function through a dual 
mechanism of action. At high concentrations of H20 2, catalase catalyzes the 
dismutation of this substrate to two HzO and one 0 2 molecule, while at low 
concentrations of H20 2, the oxygen from one equivalent of this substrate is used to 
oxidize a small number of organic compounds, such as ethanol, methanol, or guaiacol 
(Figure 1; e.g., Sichak and Dounce, 1986). Myoglobin and hemoglobin are also known 
to possess some small degree of ,;atalase activity, although the significance of this 
particular function has generally been overshadowed by that of their primary 
physiological function of oxygen storage and transport (Figure 1). Nevertheless, the 
potential importance that such protc~ins may have to do with the well-being of the cell 
should not be overlooked. The m~chanism of the catalytic decomposition of lfz02 by 
oxymyoglobin has been studied in detail (Whitburn, 1987 and references cited therein). 
But metmyoglobin and methemoglobin can also, in the presence of a suitable reducing 
agent (e.g., ascorbic acid), work in a peroxidatic mode, weakly (King and Winfield, 
Figure 1: A schematic representation of the 4 pyrrole nitrogens of the heme provides 
the backdrop for illustrating (a) the peroxidatic (or catalatic) reactions of peroxidase 
(or catalase), which are responsible for the breakdown of 2 molecules of Hz02 
(peroxide 0-0 cleavage) with the formation of a transient intermediate· known as 
Compound I. (b) A schematic representation for illustrating the function of the 
globins, which simply load and unload 0 2; note that the met species of the protein can 
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1963) eliminating "20 2 (Kellin and Hartree, 1950; King and Winfield, 1963; Harel and 
Kanner, 1989; Ortiz de Montellano and Catalano, 1985; Romero et al., 1992). In 
doing so, however, metmyoglobin is irreversibly altered through repeated reaction 
cycles (King and Winfield, 1963) and probably forms hydroxy radicals (Hare! and 
Kanner, 1988); therefore, it cannot be considered a true enzyme. Because 
metmyoglobin can form hydroxy mdicals when functioning as a catalase, this activity 
of the protein can be deleterious to the cell. It has been known for some time that 
metmyoglobin can accelerate lipid peroxidation (Kanner and Hare!, 1985; Newman et 
al., 1991), and that this activity can be modulated by NO (Kanner et al., 1980; Dee et 
al., 1991). 
The investigation of the reactions of myoglobin with "20 2 has a long history, 
starting with the work of Kellin aind Hartree (1950 and earlier). Since then, many 
studies have appeared which characterize the fine points of the reaction cycle (e.g., 
George and Irvine, 1952, 1953, 1956; King and Winfield, 1963; Whitburn, 1987; 
Tajima and Sbikama, 1993) using protein analogues of myoglobin such as 
leghemoglobin (Davies and Puppo, 1992), hemin model compounds (Kremer, 1989), 
and computer simulations (Wazawa et al., 1992). 
Heme proteins have always been the subject of intense interest in the field of 
protein chemistry, not only because of their varied and well-known physiological 
importance, but also because of theilr prosthetic group (Figure 2). Central to the active 
site of these proteins is the heme ]Prosthetic group (Figure 2), which exists in many 
different chemically similar forms (Bonnet, 1978). The hemeprotein active site 
Figure 2: The heme protein active site: Shown are the active 




















contains the heme prosthetic group, which is responsible for the physiological 
functions of each respective protein. In myoglobin, the heme group is buried in a 
mostly hydrophobic pocket with onJy one side of the heme roughly exposed to solvent. 
In catalase, the heme is deeply buried within the protein and is sandwiched between 
a hydrophobic side distally and a hydrophillic side proximally. The terms "distal" and 
"proximal" are common usage in lhemeprotein nomenclature and are abbreviated L6 
(Ligand-6) and LS (Ligand-5) site:s, respectively. In heme, the Fe is bound by four 
pyrrole nitrogen atoms, which are an integral component of the heme molecule. When 
a ligand, denoted X, gains entry to the heme pocket, it binds the Fe on the distal side 
of the heme; such a ligand is denoted L6 or distal ligand. On the opposite side of the 
heme, the proximal side, an amino acid provides the oruy linkage of the protein to the 
heme; this amino acid is a His resiidue in myoglobin and a Tyr residue in catalase. 
In an effort to understand how the active site residues structurally and 
electronically influence the heme part of the active site and reactivity in these proteins, 
many studies of synthetic heme anafogues have appeared over the past 2-3 decades 
(e.g., Hanson et al., 1981; Fujita et al., 1983; Hansen and Goff, 1984; Chen and 
Stynes, 1986; Goldsby et al., 1986; Barteri et al., 1986; Cairns et al., 1987; Mitchell 
et al., 1987; Traylor & Xu, 1987; Brown et al., 1987; Hatfield et al., 1987; Levine and 
Holten, 1988; Safo et al., 1990; Guilard et al., 1991; Hatano et al., 1991; Garcia et al., 
1991; Robert et al., 1991). A central theme in many of these studies has been the 
effects of the axial ligand(s), since, although many heme proteins have identical 
prosthetic groups, many of them dlo not have identical axial ligands. In both sperm 
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whale myoglobin (SWMb) and in the a and ~ subunits of hemoglobin, the fifth ligand, 
which is axially coordinated to th,e heme Fe, is known to be the imidazole of a His 
residue. This group provides the only linkage to the protein. However, in many 
naturally occuring hemoglobin mutants (Nagai et al., 1983; 1989), as well as in 
catalase (Murthy et al., 1981; Fita and Rossmann, 1985), this axial fifth ligand is the 
phenolate of a Tyr residue. Sperm whale myoglobin (MW 17.8 kDal) has been the 
subject of intensive investigations focused on understanding the dynamics of ligand 
binding through the use of site-din~ted mutagenesis of the heme distal pocket (Olson 
et al., 1988; Ikeda-Saito et al., 1991, 1992; Rohlfs et al., 1990; Morikis et al., 1989; 
Bellelli et al., 1990a,b; Carver et al., 1990; Egeberg et al., 1990a,b; Springer et al., 
1989; Rizzi et al., 1993) and/or the proximal side (Morikis et al., 1990; Egeberg et al., 
1990a; Adachi et al., 1991, 1993). 
The existence of hemoglobin mutants with Tyr as axial ligand led Egeberg et al. 
(1990a) to replace the proximal Hfa in SWMb with a Tyr residue using site-directed 
mutagenesis of their synthetic SVVMb gene (Springer and Sligar, 1987). Optical 
UV/visible, electron paramagnetic (EPR), and resonance Raman spectroscopies were 
used to characterize the spin and c:oordination states of the MbH93Y. Adachi et al. 
(1991, 1993) also constructed the mutant, MbH93Y, using a synthetic human 
myoglobin gene, and characterized it via optical absorption, EPR, and 1H-NMR 
spectroscopies. 
For Egeberg et al. (1990a), the rationale behind placing a Tyr residue in place of 
the proximal His in SWMb was to gain insight into the electronics and geometry of 
9 
the naturally occuring, nonfunctional hemoglobin mutants. The single, point mutation 
of the axial ligand from a His to a Tyr has resulted in profound adverse physiological 
consequences in the naturally occuring hemoglobin mutants (Nagai et al., 1983, 1989). 
Decreased activity was also found in site-directed mutants of cytochromes htt and hr, 
(Yun et al., 1991), c1 (Nakai et al., 1990), and P-450d (Shimizu et al., 1988). 
The other relevant widely studiled pro~ein is catalase (Bovine Liver Catalase, BLC; 
Nicholls and Schonbaum, 1963). This protein is known to be among the fastest 
reacting enzymes (Fersht, 1985), approaching the diffusion-controlled limit. However, 
the high degree of catalatic or peroxidatic activity found in catalase (Fersht, 1985) and 
cytochrome c peroxidase (CcP) is not found in the globins. The latter have been 
shown to also dismutate ~0 2, but only through a limited number of reaction cycles 
(ca. 8, King and Winfield, 1963), :at the end of which the structural and/or functional 
integrity of the protein has been compromised. For this reason, myoglobin cannot be 
considered an enzyme. Since SMrfb, BLC, and CcP all possess the same heme group 
at their respective active site (Poulos, 1988), the striking functional difference which 
separates the globins from the peroxidases and catalases must lie with the differences 
of both the specific residues at homologous sites and their respective spatial 
orientation; i.e., active site structure. As shown in Figure 2, all three proteins possess 
some degree of H-bonding network within their respective active site. In BLC (Fita 
and Rossmann, 1985) and CcP (Filt1zel et al., 1984), the H-bonding network is shared 
among several key residues speculated to be largely responsible for the activity of each 
respective enzyme. Therefore, it is reasonable to propose that, as a result of molecular 
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dynamics simulations and rational design, certain key residues in the nonpolar heme 
pocket of SWMb can be mutated to polar residues that are thought to reside in a 
homologous site and particular orientation, strategically poised in HEC or CcP for 
performing the chemistry of these enzymes. Although the active site structure of 
catalase and SWMb differ considerably (e.g., Poulos, 1988), the presence of identical 
axial ligands and prosthetic · grou]Ps in catalase and MbH93Y provides us with an 
excellent opportunity to investigate: the structureHfunction relationship of these active 
sites (Morikis et al., 1990; Egeberg et al., 1990a; Adachi et al., 1991, 1993). What 
unique arrangement of amino acids in the active site of catalase is responsible for 
activity that is so markedly differcmt from that of SWMb? In addition to the heme, 
as a result of site-directed mutagenesis, the proximal ligand in MbH93Y is identical 
to that in catalase. 
The purpose of this study is 2-fold: Firstly, I will confirm and extend the 
spectroscopic characterization of the proximal mutation of SWMb started by Egeberg 
et al. (1990a) using optical absorptilon and X-ray absorption (XAS) spectroscopies and 
compare the results to those obtained for recombinant wild type (WT) SWMb and 
purified HEC. Because cyanide (CN·) is the ligand of choice (see below) for 
characterizing the ligand-binding properties of the mutant, the results of the CN· 
complexes of each of these thre:e proteins are also compared; secondly, I will 
characterize the ligand-binding properties and peroxide reactivity properties of 
MbH93Y. 
11 
X-ray absorption spectroscopy is useful for determining the local structure around 
the active sites of metalloproteins (Lee et al., 1981; Powers, 1982; Strange et al., 
1990). However, XAS has several disadvantages such as (i) the inability to distinguish 
two atom ligands if they differ only slightly in atomic number, (ii) the inability to 
locate ligands more than -4 A from the metal center, and (iii) the requirement of a 
highly pure and concentrated sample. Nevertheless, despite these limitations, XAS has 
proven to be a powerful spectroscopic tool to probe the active site structure of a large 
variety of metalloproteins since the information it yields complements that obtained 
through other means, such as 1H-NMR, EPR, and x-ray crystallography. In addition, 
XAS can provide structural information within an error of± 0.015 A. 
Cyanide is an ideal ligand with which to examine the ligand-binding properties of 
the mutant heme protein, since the cyanide-ligated protein has served as a useful model 
for the binding of other diatomic li!!iands. The metcyano-complex is a good model for 
the oxy form because its large magnetic anisotropy is expected to ~duce a large 
downfield hyperfine shift for the resonances arising from the protons located near the 
ligand-binding site in magnetic resonance experiments. Cyanide also forms a stable 
hexacoordinate complex that is easic:r to handle than the carbonmonoxy - or oxy-bound 
forms of the protein. 
To functionally assess the effects of the axial mutation, I performed the following 
characterizations: (i) the mutant protein was exposed to H20 2 in order to determine if 
the mutated SWMb can form the ferryl intermediate, Compound I, which occurs in the 
peroxidatic and catalatic reactions; (ii) the mutant protein was titrated with increasing 
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concentrations of KCN in order to assess its effectiveness in binding cyanide, relative 
to the native or WT; (iii) the distal His was modified with CNBr to sterically probe 
the ligand binding dynamics of the distal pocket; and (iv) the acidHalkaline transition 




Purification of MbH93Y. Site-directed mutagenesis of the synthetic SWMb 
gene was performed by Egeberg et al. (1990a) and purification of the mutant 
myoglobin was executed as previously specified (Springer and Sligar, 1987; Egeberg 
et al., 1990a). A stab culture of Escherichia coli (E.coli) strain TB-1 transformed with 
a plasmid, pMb413a, containing the mutated SWMb gene (Egeberg et al., 1990a) was 
kindly provided by Dr. Stephen Sligar's laboratory (University of Illinois, Urbana). 
The cells were grown overnight to late stationary phase in Luria Broth (LB; 10 g 
bactotryptone, 5 g yeast extract, 10 g NaCl per liter) in the presence of 200 mg per 
liter ampicillin (Sigma), then to exponential phase for 3-4 h, and then again to late 
stationary phase in 2 liters of LB media for 2-3 days. Essentially, this procedure 
entailed diluting the cells and regrowing them. Growth was carried out at 37°C in a 
shaking incubator at 120 rpm (New Brunswick). All cells were collected by 
centrifugation (Sorvall) at 8,000 x g, 4°C, for 10 minutes. Pellets were stored at -80°C 
until at least 200 g cells had been ,accumulated. 
For purification, the cells were thawed into -600 ml ice-cold lysis buffer 
consisting of 50 mM Tris-HCl (pH 8.0), 1 mM EDTA (pH 8.0), 0.5 mM dithiothreitol, 
1 mM phenylmethylsulfonyl fluoridle (PMSF), 40 units DNase I per ml, 3 units RNase 
A per ml, and 2 mg lysozyme per ml and stirred for 6 hat 4°C. The cell debris was 
removed by centrifugation at 8,000 x g at 4°C for 20 minutes. The pellets were then 
resuspended in the lysis buffer and stirred at 4°C overnight while the supernatant was 
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stored at 4°C overnight. Twelve-16 h later, the lysed pellets and supernatants were 
combined and stirred for 2-3 h and centrifuged at 8,000 x g at 4°C for 20 minutes. 
The supernatant was then decanted and maintained at 4°C while the pellet was 
subjected to French press at 8,000 psi. The pressed pellet was then centrifuged at 
8,000 x g at 4°C for 20 minutes several times until the resultant volume of the 
supernatant was negligible. All supernatants were then combined. Solid ammonium 
persulfate was added (55% satumtion) and the solution was stirred at 4°C for -45 
minutes, then centrifuged at 6,000 x g at 4°C for 45 minutes. The pellets were 
discarded and the supernatant was stirred overnight or for several hours, after which 
fractionation with 95% ammonium persulfate was carried out This last salt 
fractionation was allowed to stir at 4°C for -1 hand then centrifuged at 6,000 x g at 
4°C, for -1 h. The supernatant was then discarded and the pellet then dissolved in a 
minimal volume of gel filtration buffer consisting of 50 mM Tris-HCl (pH 8.0) and 
0.1 mM EDTA (pH 8.0). This dissolved pellet was then stirred overnight at 4°C in 
the presence of hemin (Sigma). 
This myoglobin preparation was then applied to a Biogel P-60 (Biorad) size-
exclusion, gel filtration column (5 x 90 cm), previously equilibrated at 4°C in the gel 
filtration buffer. Fractions were collected and the decision of which fractions to pool 
was determined by optical absorption spectra (Shimadzu UV /visible scanning 
spectrophotometer--UV 2101PC) and by sodium dodecylsulfate-polyacrylamide gel 
electrophoresis (SOS-PAGE, Laemmli, 1970). The optical spectra and SOS-PAGE 
were used to determine the exte;mt of purity. The narrow width of the various 
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absorption bands (Soret, charge transfer, ~. ex) in the optical spectra would have 
indicated that the myoglobin was free of impurities and the respective fractions that 
exhibited one band on the silver-stained polyacrylamide gel that electrophoresed to the 
position corresponding to -17 .8 kDal would also have indicated a highly pure protein. 
The fractions that corresponded to the optical absorption peaks and to the 17 .8-kDal 
band on the gel were pooled. These pooled fractions were then dialyzed at 4°C, 
overnight, in several changes of 20 mM phosphate buffer, pH 6.7, followed by 
application to a CM-52 (Whatman) cation exchange column (2.6 x 30 cm) previously 
equilibrated in the dialysis buffer. Once again, fractions were collected and both the 
optical spectra and SOS-PAGE were used to determine which fractions to pool and 
concentrate under Ar in an ultrafiltration cell (Amicon). 
Purification of Wild-Type Sperm Whale Myoglobin. Wild-type SWMb was 
purified using the method of Springer and Sligar (1987), which is identical to that used 
for the purification of MbH93Y and was discussed above. Again, the extent of purity 
at each stage of purification was dleterminined by its optical spectra and SOS-PAGE. 
Native Sperm Whale Myoglobin. Native SWMb was purchased from Sigma. 
The protein was further purified to remove isozymes, as well as any extraneous debris 
according to the method of Powers et al. (1987). Briefly, a known amount of native 
SWMb was weighed and dissolved in a known volume of 0.1 M phosphate buffer at 
pH 7.0 and dialyzed against this buffer for 12-16 h (overnight), with 2-3 changes at 
4°C. The precipitate obtained following centrifigation at 10,000 x g for 30 minutes 
at 4°C was discarded. The pH of the supernatant containing the myoglobin was 
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adjusted to 6.4 and the solution applied to a cation exchange column (Whattnan, CM-
52) previously equilibrated at 4°C with 0.1 M phosphate buffer, pH 6.5. The optical 
spectra and SOS-PAGE confirmed that the fractions to pool were those of the dark 
brown band that eluted off the column. The purified native protein was then 
concentrated under Ar through an ultrafiltration cell (Amicon). 
Horse Erythrocyte Catalase . Horse erythrocyte catalase was purified according 
to the method of Nagahisa (1962). Briefly, 1 liter of horse blood was collected in a 
chilled glass jar containing 5% citrate as anticoagulant and centrifuged at 8,000 g at 
4 °C for 20 minutes, after which the hematocrit was measured. The supernatant 
containing the plasma and citrate was discarded and the erythrocytes were gently 
washed with isotonic saline 3-4 times and centrifuged following each wash. Following 
the final decant of the isotonic saline, the erythrocytes were lysed in a volume of cold 
water equal to twice the initial volume of erythrocytes and was left to hemolyze at 4°C 
overnight. Following complete hemolysis, a volume equal to that of the initial 
erythrocytes of cold ethanoVchloroform (3:1) was slowly added at 10-20°C under 
constant stirring to precipitate the hemoglobin. The extemely viscous slurry was then 
filtered through Whattnan #1 filter paper on a large ribbed, conical funnel. The 
organic phase was then evaporated off as quickly as possible, while the temperature 
was maintained at 12-15°C. Then, 1 M acetate buffer at pH 4.7 was added to make the 
concentration of acetate equal to O. l M, pH 4.4. The protein/solvent mixture was then 
centrifuged at 8,000 x g at 4°C for 20 minutes and the pellets were discarded. 
Acetone was slowly added while stirring at 4°C, until the mixture became cloudy 
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(usually~ 15-30% by volume), afte:r which, the solution was centrifuged and the pellet 
was discarded. The preceding step of acetone addition was repeated until the 
supernatant again became cloudy; the solution was then centrifuged. The resulting 
supernatant was discarded and the: pellet dissolved in a minimal volume of 0.1 M 
acetate buffer at pH 4.7, centrifuged at 8,000 x g at 8-12°C for 15 minutes and the 
pellet discarded. The protein was then precipitated by the slow addition of solid 
ammonium persulfate to 35% saturation while stirring at 4°C for 1 h. The solution 
was then centrifuged at 8,000 x g at 4°C for 20 minutes and the precipitate discarded. 
Finally, the protein was dialyzed against 0.01 M phosphate buffer, pH 6.2, at 4°C with 
several changes of dialysis buffer over a 12-18-h period. To determine the purity of 
the HEC, optical spectra were recorded and native (non-denaturing) gel electrophoresis 
was performed. The~ value (Abs,W<imnl'Abs~ was determined to be 1.25 and is in 
excellent agreement with the previously reported value for HEC (Nicholls and 
Schonbaum, 1963). The catalase was then concentrated in an ultrafiltration cell 
(Amicon) under N2• 
The HEC was assayed for its ability to decompose Ri02, using the method of 
Beers and Sizer (1952). Briefly, HEC was added to a final concentration of 10·10 M 
in 10 mM phosphate buffer at pH 6.3 in a reaction volume containing -48 µM H20 2• 
For each successive reaction, the concentration of Ri02 was held nearly constant, but 
the concentration of HEC was increased incrementally for each reaction up to - 10·9 
M. The kinetics for the dismutation was followed at 240 nm for 2 minutes. 
Formation of Compound I was followed according to the method of Jones and 
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Middlemiss (1972) and Palcic and Dunford (1980). Briefly, catalase compound I was 
made by titration of a known concentration of HEC with an increasing amount of 
peracetic acid until the molar ratio of peracetic acid to catalase was 1.2 (Jones and 
Middlemiss, 1972). The ratio of Abs406im/Abs410mn, which represents the ratio of 
compound I/native catalase, was calculated to be 0.478 and agrees with the previously 
published value of Nicholls and Schonbaum (1963). 
Heme integrity of HEC as well as of the myoglobins was determined using the 
pyridine haemochromagen assay according to the method described by Paul et al. 
(1953). Briefly, to -20 µM protein in 1 ml lfiO, 2 µI pyridine, 70 mM NaOH, -10 
mg sodium dithionite and lfiO were added to a final volume of 5 ml. The optical 
spectra were recorded and the ratio of Abs557nn/ Abs527mn yielded the concentration of 
the protein sample. If this ratio e:quals 2.0, then the catalase tetramer has all four 
hemes intact. If, however, this ratio is less than 2.0 and/or there is absorbance at -650 
nm, then broken hemes are present. 
Cyanide-Bound Horse Erythrocyte Catalase. For the XAS studies, HEC was 
mixed with micromolar concentrations of KCN and placed into the EXAFS holder. 
Formation of the Various Liganded Forms (CO, 0 2, CN) and Oxidation States 
(Fe3+, Fe2+) of Myoglobins. The WT, native, and MbH93Y myoglobins were purified 
in the met (Fel+) oxidation state. Subse:quent formation of the various liganded forms 
as well as of the various oxidation states was facilitated by use of an air-tight vessel, 
which was composed of an inlet and an outlet valve, both of which fed into a common 
resevoir and were connected to a common neck that led to the top of a 3-ml capacity 
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cuvette. Before each of the different forms was made, the myoglobin solution was 
purged with Ar through this air-tight vessel. The reduced (Fe2+, deoxy) form of each 
myoglobin was prepared by the addition of a small amount (several crystals) of sodium 
dithionite in the resevoir of the air-tight vessel. The carbon monoxy form (CO) of 
each myoglobin was then prepared by bubbling CO into the inlet valve of the vessel 
leading into the cuvette in semi-darkness containing the reduced form. The oxy form 
(Oz) of each myoglobin was prepared by bubbling 0 2 into a cuvette containing a 
freshly prepared reduced form at 4°C. Finally, the cyanomet (CN·) form of each 
myoglobin was prepared from the met (Fe3+) form by the addition of the stoichiometric 
amount of KCN from a concentrated stock solution. Once made, each form of each 
myoglobin was sealed in the air-tight vessel and then scanned for its optical 
absorption. 
Extinction Coefficients. Mlillimolar extinction coefficients were determined 
using the pyridine haemochromagen assay of Paul et al. (1953). Briefly, to -20 µM 
protein in 1 ml H20, 2 µl pyridine, 70 mM NaOH, -10 mg sodium dithionite and HzO 
was added to a final volume of 5 ml. The optical spectra were recorded and the ratio 
of Abs557mJ Absmmn yielded the concentration of the protein sample. Using the 
Lambert-Beer relationship, e403_ == Abs/cl, where c = concentration and 1 is the path 
length of the sample cuvette (1 = 1 ), the millimolar extinction coefficient was 
calculated. The working concentrations of all reactions involving either the native or 
WT SWMb were determined using the millimolar extinction coefficient of 168 mM· 
1cm·1 (Clark and Gurd, 1967), a value I confirmed. The working concentrations of all 
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reactions involving MbH93Y were:: determined using the calculated £403 = 169.46 mM· 
icm•t. 
Reactions with H2O2• Reacitions with either 2-fold molar excess H20 2 or 4-fold 
molar fewer equivalents with respect to myoglobin were followed 
spectrophotometrically at l-minu1te intervals. All reactions were maintained at a 
constant temperature of 23°C • by a thermojacketed cuvette holder (Brinkman). 
Reactions with KCN. Recombinant SWMb, native SWMb, and MbH93Y were 
each titrated with increasing concentrations of KCN (Malinkrodt) in 0.1 M low ionic 
strength MES/MOPS buffer at pH values of 5.5, 6.0, 6.5, 7.0, 7.5, and 8.0. Again, all 
reactions were maintained at a constant temperature of 23°C. Dissociation constants 
(Ko) were determined by calculation of the differences in absorbances for unbound 
protein, bound protein, and unbound ligand according to the method used by 
Schonbaum (1973). From the absorption spectra of each individual titration of 
myoglobin with increasing concentrations of KCN, the inverse of the total cyanide 
concentration ([CN·]), [CN·h· 1 x 1()3 is plotted as a function of the inverse of the 
change in absorbance, 1!,.A1, at 409 nm (native and WT SWMb) or 403 nm (MbH93Y) 
and at 423 nm (CN·-bound myoglobin, MbCN). The inverse of the slope of the line 
is equal to the K0 • The concentration of MbCN ([MbCN]) was calculated using the 
relation, [MbCNJ = Moo/dE-r, where M 0 .,,. is the change in the observed absorbance 
and df-r is the change in the toital extinction coefficient and is equal to (KD x 
slope)l[Mblr = MmaJ[Mb]r, where ~ax is the maximum change in absorbance and 
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[Mbh is the total concentration of myoglobin in all forms (free Mb and CN·-bound 
Mb). 
Kinetics of the forward rate of reaction of CN· binding to the protein were 
calculated (Vega-Catalan et al., 1986) using the relation k+J(oppJ = Kv x k.J(oppJ• where 
k+icapp) and k.1<•PP> are the apparent forward and reverse rate constants, respectively, of 
the reaction Mb+ + CN· <=> MbCN. The same experiments as those used for 
determining the binding constants were used for the kinetic analyses. 
Cyanogen Bromide Modification of Myoglobins. All three myoglobins 
(recombinant, native, and MbH93Y) were reacted with CNBr (Aldrich) according to 
the procedure first used by Jajczay (1970), except that -100-fold excess, rather than 
stoichiometric amounts (Jajczay, 1970) of CNBr were used relative to each protein. 
The reaction with CNBr therefore followed pseudo first-order kinetics. The UV/visible 
spectra were recorded and the rate of decrease of the Soret band was monitored 
following the addition of molar equivalents of H20 2 to myoglobin (native or 
MbH93Y). 
AcidHAlkaline Transitions. The acidHalkaline transition profiles of native 
SWMb and MbH93Y were determined in both the forward and reverse directions with 
increasing concentrations of NaOH and HCl, respectively. Proton dissociation 
constants (pK.) were determined from a plot of the percent change in absorbance as 
a function of pH (Yamazaki et al., 1974). Hill coefficients were calculated graphically, 
log[y/(1-y)] vs. pH, where y is the fraction of sites filled and 1-y is the fraction of sites 
not filled. The slope of this line is n. 
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XAS Data Collection and )lnalysis. XAS experimental data were recorded at 
the Stanford Synchrotron Radiation Laboratory (SSRL), Stanford, CA, on Beamlines 
VI-2 and IV-3, and at the National Synchrotron Light Source (NSLS), Brookhaven 
National Laboratory, Upton, NY, on Beamline X9, using procedures and experimental 
parameters identical to those previously described (Powers et al., 1981; Chance et al., 
1984; Powers et al., 1984, 1987; Sinclair et al., 1992). The beamline monochromators 
at both sources were equipped with Si 111 crystals providing 2-3 eV resolution at the 
Fe K-edge (7,110 eV) (Sinclair et al., 1992). Fluoroscence was monitored using a 13-
channel Ge detector. Data for all myoglobin samples were collected at both the NSLS 
and SSRL while that for HEC was collected at only NSLS. The data were recorded 
by counting the fluorescence photons emitted from the sample at specific energies. 
Scans ranged from 7,050 to 7,800 eV (Figure 3) and were analyzed by procedures 
described previously (Powers et al., 1981; Lee et al., 1981; Powers et al., 1984). The 
fractional modulation of the absorption due to EXAFS, which is deduced from XAS 
data, is 
x;(k) - LA1(k) sin{2[kr1 + ~(k)]} 
where A1(k) - ~ ex.p[-2a/k2] exp[-2r/A.(k)] fork::?: 4 A.·1 
k3r/ 
and k - CEx-ray - Eo]1''2 
Figure 3: Representative scans of Wf SWMb (top), MbH93Y (middle), 
HEC (bottom) and of their cyanide-ligated complexes. Shown for each 
protein is a typical x-ray absorption spectrum where, above threshold, 
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where Alk) is the amplitude, which describes the magnitude of the interference and 
depends only on the scattering atoims, the chemical nature of which is determined by 
a back-scattering factor Uf(k, 1t)/] -- 'ZN'; an r·2 factor is due to the spherical nature of 
the waves, each possessing an r·1 dependence; a Debye-Waller factor exp[-2crk2] 
describes the attenuation of the oscillations due to thermal and lattice disorder 
producing an uncertainty in r; and the finite lifetime of the photoelectron is described 
by a mean free path exp[-2r/A.(k)]. The sine term is the total phase change and is due 
to the potential of both the absorbing and scattering atoms and the change in distance 
the photoelectron takes in its round-trip journey . N is the number of neighboring 
atoms. 
Six to eight scans comprised the data from each light source and were analyzed 
separately to enhance the signal-to-noise ratio (S/N). This was followed by 
background subtraction using a least squares procedure. Multiplication by k3 followed, 
where k is the photoelectron wave vector (Figure 4) and is equal to 21t/A,e1ecrron where 
the denominator is the wavelength of the photo-electron. The EXAFS modulations 
from each light source were weighted in averaging according to their respective SIN 
ratio. The modulation covering k=0-12 .5 A-1 was used for further analysis. Although 
limiting the modulation below k-13 A·1 may result in some loss of resolution of 
Fourier transform spectra, it reduces the background noise level of the Fourier 
transform (Figure 5). The last wiggle of the modulation should have a SIN of 2/1. 
The weighted EXAFS spectrum is Fourier transformed in order to isolate contributions 
from respective coordination shells (Figure 3). The first peak (major peak) of the 
Figure 4: Background-subtracted EXAFS data normalized to one Fe 
atom and multiplied by k3. (a) Ferric states of WT SWMb (top), MbH93Y 
(middle), and HEC (bottom). (b) CN· derivatives of WT SWMb (top), 
MbH93Y (middle), and HEC (bottom). 
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Figure 5: Fourier transfo:rmations of the EXAFS data of Figure 4. 
(a) Ferric states of WT SVVMb (top), MbH93Y (middle), and HEC (bottom). 
(b) cyanide derivatives of WT SWMb (top), MbH93Y (middle), and HEC 
(bottom). 
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Fourier transform resulting from the first shell scattering wave signal was filtered and 
backtransformed into k space (Figure 6) and yields the phase component <I> = 2kr + 
q>(k) for a single-distance system and is used to extract the interatomic distance, r, if 
<!>(k) is known for a model compound (Figure 6). Three model compounds, Fel+-
bis(imidazole-tetraphenylporphinato )chloride (FeTPP(lm)z), Fe2+ -acetylacetonate (Fe2+ -
acac), and Fel+-acetylacetonate (Fi~l+-acac) were treated with the same procedures as 
described above except that transmission mode was used for data collection. For 
FeTPP(Im) 2, the Fe-N bond length is 1.986 A (Collins et al., 1972) and for Fe2+-acac 
and Fel+-acac, the Fe-O bond length is 1.990 A (Iball and Morgan, 1976). The 
scattering signal derived from the first transform peak of each protein was fitted to that 
of the model compounds with two types of scattering atoms. Each atom type in the 
fitting procedure is represented by an average distance (r), an amplitude factor 
containing the number of ligands (n), a change in the Debye-W aller factor (.1er = 
er model - er protein) and a change in threshold energy (Al;, = Eaiodel - Eprotein). Because the 
number of scatterers is highly correlated with .1er, precautions were taken to avoid 
erroneous results, which have been described in detail by Powers (1982). In this study, 
the two-scatterer nonlinear least squares fitting procedure with amplitude ratios was 
fixed at 4:2 to search parameter space for the scattering from the Fe-porphyrin (Fe-NP) 
or 5:1 for the scattering from the Fe-axial ligand (Fe-Nt or Fe-O). Several possible 
solutions were judged to be statis1tically different only if the I.R.2 > ~ 2(1 + ~/), 
where L~m 2 is the minimum sum of residuals for a physically reasonable solution, ~r 
= <l>d - p, where p is the number of variables in the fit and <l>d is the maximum number 
Figure 6: Comparisons among the first-shell filtered data for each 
protein. (a) Ferric states of WT SWMb (top), MbH93Y (middle), and 
HEC (bottom) and (b) Cyanide derivatives of WT SWMb (top), MbH93Y 
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of degrees of freedom in the filtered data. The variable <l>d was estimated by 2~w&./rc, 
where ~w is the width of the filtc::r window used for the Fourier transform peak and 
Afc was the length of the data used. After solutions were found for each contribution 
to the first shell (Fe-Np, Fe-Ne, Fe-O, or Fe-C), a three-atom consistency test was 
carried out using all three sets of scatterers with r and n held constant for each set of 
scatterers in order to verify that all three distances were contained in the data. The 
l::R2 for the consistency test must be smaller than those obtained for the two atom-type 
solutions. To ensure that the three distances obtained from the above steps constitute 
a true minimum, each distance was allowed to vary one at a time. Total error for each 
distance was determined by changing it to a different value while holding all other 
parameters constant in the fitting :procedure until the sum of the l::R2 increased by a 
factor of two on each side of the minimum. The Hessian matrix, which also 
determines the errors for each parameter, was used to determine how much the 
parameters can be adjusted and still lie within the error. Some of the errors were not 
symmetric around the minimum value, in which case, the larger value of the errors was 
taken into account in the results. A detailed discussion of error analysis has been 
previously provided (Powers and IGncaid, 1989). 
Inasmuch as various complicated physical processes, such as chemical bonding 
effects and core relaxation, are involved in the absorption process near the threshold, 
no simple relationship has been d1efined for the features and E0, which was used to 
compute k (Lee et al., 1981). To prevent an ambiguous answer, three arbitrary points 
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for E0 were initially chosen for the comparison of X(k). It is important to note that 
Eo is a variable in the fitting proc1edures. 
The ligand field indicator ratio (LFIR) was calculated according to Chance et al. 
(1984; Figure 7). It was calculated by drawing a perpendicular line from the inflection 
points on the horizontal baseline of the normalized X-ray spectrum to each of the two 
peaks, labeled A and B. The LFIR was then calculated as the ratio of the lengths of 
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UV/Visible Spectroscopy. The electronic absorption spectra of the met-, 
cyanomet, reduced, CO, and oxy forms of both the MbH93Y and WT· SWMb are 
displayed in Figure 8 and Table 1; the latter also displays the results obtained by 
previous investigators for comparison. 
In this study, we confirm and complement the spectroscopic studies initiated by 
Egeberg et al. (1990a) and Morikis et al. (1990) using UV/visible and XAS 
spectroscopies. We were able to ll'eproduce the optical absorption spectra of three of 
the liganded forms, 0 2, CO, and cyanomet, and the Fe3+ (met) and Fe
2+ (Table 1) 
reported earlier by four other groups (Table 1; Egeberg et al., 1990a; Adachi et al., 
1991; Dawson et al., 1992; Tsai et al., 1993) of a mutant myoglobin in which the 
native proximal His was mutated to a Tyr residue. The Soret peak (A = 403 nm) 
mi11imolar extinction coefficient (~I03nuJ of MbH93Y was determined to be 169.46 mM· 
1cm·1• Note that the met form of MbH93Y, like that of the WT protein, is high spin. 
However, unlike the WT protein, 1the Soret band of the mutant is significantly blue-
shifted relative to WT SWMb (Talble 1) which suggests pentacoordination. 
Horse Erythrocyte Catalasii. Because the hemes of purified BLC are often 
degraded to bile pigments (Nicholls and Schonbaum, 1963; Palcic and Dunford, 1980), 
we have purified catalase from horse erythrocytes ~ = 1.25) and have shown by 
haemochromagen assay (Paul et al., 1953) that no degraded hemes are present. Both 
the pseudo first-order rate constant and apparent rate constant for the dismutation of 
Figure 8: Optical absorption spectra of the various oxidation 
and liganded states of Wild-Type Sperm Whale Myoglobin and 
MbH93Y. All forms were made in 20 mM phosphate buffer, pH 7.0, 
at 23°C. (a) met WT SWMb and met MbH93Y. (b) Cyanomet WT SWMb 
and cyanomet MbH93Y. (c) Reduced, oxy and carbonmonoxy forms 
of Wild-Type Sperm Whale Myoglobin. (d) Reduced, oxy and 












































Table 1: Optical Absorption Peak Data of the Met, Cyanomet, Carbon-Monoxy, 
Reduced and Oxy Forms of Wild-Type Sperm Whale Myoglobin and MbH93Y. 
Soret 
Met (Fe3•) 
MbH93Y 403 (402) 483 (480) 515 (524) 597 (598) 
WTSWMb 408 (408) 504 (502) 632 (632) 
Reduced (Fe2•) 
MbH93Y 427 (428) [427] 564 (556) [560] 
WTSWMb 433 (432) [433] 555 (554) [558] 
Oxy (Fe2•) f3 a 
MbH93Y 420 (~414) [414] 542 (540) [540] 568 (576) [576] 
WTSWMb 423 (418) [417] 542 (544) [543] 577 (580) [580) 
Carbon-monoxy (Fe2•) f3 a 
MbH93Y 419 (418) [420] 539 (536) [539] 569 (568) [567] 
WTSWMb 422 (422) [422) 542 (542) [541) 578 (578) [579] 
-. 
Cyanomet (Fe3•) f3 
MbH93Y 419 [421] 550 [550] 
WTSWMb 423 424d 4231 542 541 d 5401 
Specifically, the most significant absorption maxima are shown for the various 
liganded forms of WT SWMb and MbH93Y. Values for this study are shown in plain 
text. For comparison, values from Egeberg et al. (1990a) are shown in parentheses 
( ), while those of Adachi et al. (1991) are shown in brackets [ ]. For the cyanide-
liganded forms, values marked with a superscripted 1 refer to those of Tsai et al. (1993) 
or a superscripted d refer to those of Dawson et al. (1992). 
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ffzO2 were determined to be k' = 2.415x10·2 sec·1 and Jc.w = 1.793x107 M·1 sec·1, 
respectively, which are in agreement with previously reported values (Nicholls and 
Schonbaum, 1963). Finally, our purified HEC was able to form Compound I in the 
presence of ffzO2 (Palcic and Dunford, 1981). 
XAS Spectroscopy. The LFIR ratios of WT SWMb, MbH93Y, and HEC, and 
of their cyanide-ligated complexes,. are shown in Figure 9, the calculations from which, 
are shown in Table 2 with their cmresponding Fe-out-of-heme plane distances (Fe-Cr) 
(Chance et al., 1986a). These values are consistent with the average Fe-to-pyrrole 
nitrogen (Fe-NP) distances (Chance: et al., 1984; Chance et al., 1986b) of 2.045 (WT 
SWMb), 2.04 (MbH93Y), 2.03 (HEC), 2.00 (WT SWMb-CN), 1.96 (MbH93Y-CN), 
and 2.01 (HEC-CN). However, mlllltiple scattering is responsible for the shape of the 
LFIR which can also be affected by ruffling of the heme plane. 
Table 3 shows the results of the two-atom-type fitting procedure for the met 
(Fel+) form of WT SWMb at pH 7 .0 and these are identical to those previously 
reported (Chance et al., 1983; Powers et al., 1984). The two-atom-type fitting 
procedure shows that 2.14 ± 0.02 A. (Solution A) and 1.97 ± 0.015 A (Solution B) are 
the axial ligand distances. To confirm these distances, we used a three-atom-type 
consistency test; the results are shown as Solution C at the bottom of Table 3. Since 
nitrogen has only one fewer electron than oxygen, the analysis cannot distinguish 
between the scattering amplitude of these two atoms. Thus, the Fe-N and Fe-O models 
yield the same results. However, :the sixth ligand is probably the oxygen atom of a 
water molecule, since our sample i:s the metaquo form of SWMb. Therefore, the Fe 
Figure 9: The ligand field indicator regions of (a) Wild-Type 
Sperm Whale Myoglobin (top), MbH93Y (middle), Horse Erythrocyte 
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Table 2: The Ligand Field Indicator Region Ratios and Corresponding Fe-Out-of-
Heme Plane Distances (Fe-Cr) (Chance et al., 1986a) of Wild-Type Sperm Whale 
Myoglobin, MbH93Y and Horse Erythrocyte Catalase and Their Cyanide-Ligated 
Complexes. 
WT MbH93Y HEC WT MbH93Y HEC-CN 
SWMb SWMb-CN CN 
LFIR 1.20 1.37 1.34 0.81 0.70 1.00 
Fe-C,. 0.40 0.50 0.50 0.15 0.10 0.30 
Distances of Fe-Cr are in A. Each ratio has an error of ± 0.05, which corresponds to 
an error of ± 0.03 A for the Fe-Cr distance. 
Table 3: Results of the Two-Atom-Type Fitting Procedure and Three-Atom Consistency 
Test for the First Coordination Shc~ll of Wild-Type Sperm Whale Metmyoglobin at pH 
7.0. 
Model" r' NC llcr2 d flEo• l:R2 
A Fe-N 2.03 5 2.9x1()·3 0.7 1.4 
Fe-N 2.14 1 5.lx10 ·3 0.4 
B Fe-N 2.06 5 2.2xl0" 3 0.5 1.4 
Fe-N 1.97 1 5.4xl0- 3 1.2 
C Fe-N 2.045±0.015 4 3.8xl0- 3 0.0 1.0 
Fe-N 2.15±0.02 1 4.7xl0- 3 2.1 
Fe-O 1.98±0.03 1 l.6xl0- 3 1.0 
• Each solution for a set of models is designated by a bold upper-case letter. b r, Fe-ligand 
distance in angstroms. c N, number of ligands, held constant d /lcr2, difference in Debye-
Waller factor (model-protein) in square angstroms± 45%. e .tllio, difference in threshold 
energy (model-protein) in electron volts± 2.5 eV. 
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of metSWMb has four pyrrole nitrogen ligands at an average distance of 2.045 ± 0.015 
~ one axial ligand at 2.14 ± 0.02 ~ and a second axial ligand at 1.97 ± 0.03 A. 
The fitting procedure for MbH93Y is shown in Table 4. Inspection of Table 
4 reveals our search of parameter space for possible two-atom type solutions. 
Although many solutions exist (Table 4), elimination of some of these solutions as 
possibilities was based upon the large AEo values (e.g., Solution D). Specifically, the 
solution is not any better when total N = 6 (Solutions B, F, H), than when total N = 
5 (Solutions A, E), as revealed by the ~R2, strongly indicating that only five ligands 
are bound to the Fe. That is, even when the attempt was made to fit total N = 6 
ligands, the m2 was no different. And when the magnitude of the AEo values are 
taken into account, the amplitude ratios of 4/1 gave better m2 values than those of 
5/1. The three-atom-type consistency test (Solution H), therefore, confirms that 
MbH93Y has only five ligands. 'I'he average Fe-pyrrole nitrogen distance is 2.04 ± 
0.015 ~ while the length of the p:roximal Fe-O bond is 2.13 ± 0.02 A. 
We applied the same fitting procedures described above for HEC (Table 5), 
where the two-atom-type fitting procedures revealed axial ligand distances of 1.92 ± 
0.02 A. (Solution B) and 2.11 ± 0.03 A. (Solution C). A three-atom-type consistency 
test (Solution E) revealed the average Fe-pyrrole nitrogen ligand distance to be 2.03 
± 0.015 ~ proving to be no different from those of either WT metSWMb or MbH93Y. 
This agreed well with the two-atom-type fits for axial ligand distances (Solutions B 
and C). 
Among these three proteins,, the only significant differences in bond lengths 
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Table 4: Results of the Two-Atom-Type Fitting Procedure and Three-Atom 
Consistency Test for the First-Coordination Shell of MbH93Y at pH 7.0. 
Model• r' NC t:.CJ2 d M1.o. m:2 
A Fe-N 2.03 4 5.2x10· 3 -1.7 1.0 
Fe-N 2.13 1 9.5x10 ·3 2.7 
B Fe-N 2.01 5 4.3x1()·3 -1.1 0.8 
Fe-N 2.12 1 9.3x10· 3 11.3 
C Fe-N 2.04 5 1.3x10"3 -2.5 2.1 
Fe-N 1.68 1 -8.3x1Q·3 -13.5 
D Fe-N 2.04 4 1.9x1()·3 -1.2 2.5 
Fe-N 1.76 1 -l.6x1Q· 3 -39.5 
E Fe-N 2.06 4 5.3x10· 3 -0.7 0.8 
Fe-N 1.95 1 9.3x1()·3 -5.0 
F Fe-N 2.06 5 4.lx10· 3 -1.1 1.2 
Fe-N 1.96 1 8.8x10"3 -11.1 
G Fe-N 2.03 5.02 1.5x10"3 -1.2 2.8 
H Fe-N 2.04±0.015 4 4.7x10· 3 -0.7 1.2 
Fe-O 2.11±0 .03 1 5.4xW-3 10.5 
Fe-N 1.95±0 .02 1 4.lx10· 3 -2.7 
• Each solution for a set of models is designated by a bold upper-case letter. b r, Fe-
ligand distance in angstroms. c N, number of ligands, held constant. d Iler, difference in 
Debye-Waller factor (model-protein) in square angstroms ± 45%. e llE0, difference in 
threshold energy (model-protein) in electron volts ± 2.5 eV. 
39 
Table 5: Results of the Two-Atom-Type Fitting Procedure and Three-Atom Consistency 
Test for the First Coordination Shell of Horse Erythrocyte Catalase at pH 7 .0. 
Model" r" No Acr2 d Lillo. l:R2 
A Fe-N 2.04 5 8.6xlo-4 -0.7 4.2 
Fe-0 1.94 1 3.9xl0- 3 4.8 
B Fe-N 2.03 4 3.6x10"3 -0.6 6.6 
Fe-0 1.92 1 5.0xl0- 3 4.8 
C Fe-N 1.98 4 6.lxl0- 3 1.8 6.4 
Fe-0 2.11 1 6.3xl0- 3 -3.3 ·-
D Fe-N 1.99 5 3.8xl0- 3 0.9 3.4 - -
Fe-0 2.13 1 3.4xl0- 3 -3.1 
E Fe-N 2.03±0.015 4 3.0x10"3 -0 .3 3.3 
Fe-0 1.92±0.02 1 3.7xl0- 3 5.3 
Fe-0 2.11±0.03 1 - 1.5x10·2 -4.3 
• Each solution for a set of models is designated by a bold upper-case letter. b r, Fe-
ligand distance in angstroms. c N, number of ligands, held constant. d ~cf. difference in 
Debye-Waller factor (model-protein) in square angstroms ± 45%. e Lillo, difference in 
threshold energy (model-protein) in electron volts ± 2.5 eV. 
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were (i) the proximal ligand distance of WT SWMb and MbH93Y is -0.2 A longer 
than that of HEC; (ii) the sixth ligand distance of WT SWMb is -0.14 A shorter than 
that of HEC; and (iii) MbH93Y has no sixth ligand. 
The results for the first coordination shell analysis for WT SWMb-CN are 
summarized in Table 6. The ~R~~ for the three-atom consistency test (Solution C) is 
more than a factor of 2 smaller than thos_e of the two-atom-type fits (Solutions A and 
B). Error analysis of each bond length value indicated that 2.00 ± 0.015 A is the 
average Fe-NP bond length and that 2.10 ± 0.02 A and 1.87 ± 0.03 A are probable 
solutions for the axial ligands within the first coordination shell. 
Similarly, the results for the first coordination shell for MbH93Y-CN are 
provided in Table 7. Again the three-atom-type consistency test (Solution C) is more 
than a factor of 2 smaller than those of the two-atom-type fits (Solutions A and B). 
Therefore, after error analysis of each bond length value, the final solution for the first 
coordination shell is 2.07 ± 0.02 J~ (Fe-O), 1.84 ± 0.03 A (Fe-CN), and 1.96 ± 0.015 
A (average Fe-NP). 
Finally, the results for the first coordination shell for HEC-CN are summarized 
in Table 8. The three-atom-type i:onsistency test (Solution C) is about 30% smaller 
than that with an N of 5/1 (Solution A). The resulting final solution after error 
analysis of each bond length for the first coordination shell was 2.12 ± 0.02 A (Fe-O), 
1.87 ± 0.03 A (Fe-CN), and 2.01 :± 0.015 A (average Fe-NP). 
Among these three cyanide-bound proteins, the only significant differences in 
bond lengths were (i) the proximal bond length of MbH93Y-CN is -0.05 A shorter 
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Table 6: Results of the Two-Atom-Type Fitting Procedure and Three-Atom Consistency 
Test for the First Coordination Shell of Cyanide-Ligated Wild-Type Sperm Whale 
Myoglobin at pH 7 .0. 
Model" r' NC Acf d Lillo. m2 
A Fe-N 1.98 5 5.7x10·3 -3.9 7.2 
Fe-N 2.10 1 1.3x10·2 -1.2 
B Fe-N 2.03 5 6.3x10·3 -6.2 8.0 
Fe-N 1.89 1 1.2x10·2 -3.6 
C Fe-N 2.00±0.015 4 6.8xl0- 3 -1.9 3.0 
Fe-N 2.10±0.02 1 8.5x10·3 -6.6 
Fe-C 1.87±0.03 1 8.5xl0- 3 0.3 
• Each solution for a set of models is designated by a bold upper:.case letter. b r, Fe-
ligand distance in angstroms. c N, number of ligands, held constant. d dcr2, difference in 
Debye-Waller factor (model-protein) in square angstroms ± 45%. e Lllio, difference in 
threshold energy (model-protein) in 1electron volts ± 2.5 eV. 
Table 7: Results of the Two-Atom-Type Fitting Procedure and Three-Atom-Consistency 
Test for the First-Coordination Shelll of Cyanide-Ligated MbH93Y at pH 7 .0. 
Model" r' NC Acf d Lillo. m2 
A Fe-N 1.95 5 4.2xl0- 3 -2.2 9.8 
Fe-N 2.06 1 5.lxl0- 3 -5.4 
B Fe-N 1.98 5 3.7xto- 3 -3.1 9.9 
Fe-N 1.89 1 6.lxW- 3 0.2 
C Fe-N 1.96±0.015 4 5.5xl0- 3 -2.7 4.2 
Fe-O 2.07±0.02 1 2.4xl0- 3 -5.2 
Fe-C 1.84±0.03 1 1.0xto-3 9.6 
• Each solution for a set of models is designated by a bold upper-case letter. b r, Fe-
ligand distance in angstroms. c N, number of ligands, held constant. d dcr2, difference in 
Debye-Waller factor (model-protein) in square angstroms ± 45%. e Lllio, difference in 
threshold energy (model-protein) in electron volts ± 2.5 eV. 
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Table 8: Results of the Two-Atom-Type Fitting Procedure and Three-Atom Consistency 
Test for the First-Coordination Shc~ll of Cyanide-Ligated Horse Erythrocyte Catalase at 
pH7.0. 
Model" r' N• ll<r d llEo. mz 
A Fe-N 2.04 5 -1.lxI0·3 -4.2 7.5 
Fe-O 1.89 1 - 7.7x10·3 -1.4 
B Fe-N 1.97 5 -1.2x10·3 -3.0 8.7 
Fe-O 2.12 1 4.4x10·3 -7.7 
C Fe-N 2.01±0.015 4 5.lxt0· 3 -2.8 5.3 
Fe-O 2.12±0.02 1 - 5.4xt0· 3 -7.8 
Fe-C 1.87±0.03 1 - 4.6x10·3 3.4 
• Each solution for a set of models is designated by a bold upper-case letter. b r, Fe-
ligand distance in angstroms. c N, number of ligands, held constant. d !::t.cr2, difference in 
Debye-Waller factor (model-prote:in) in square angstroms ± 45%. e .illi0, difference in 
threshold energy (model-protein) in electron volts ± 2.5 eV. 
than that of HEC-CN and (ii) the average the Fe-NP bond length of MbH93Y-CN is 
-0.04 A shorter than in WT SWMlb-CN and HEC-CN. 
-
When each of these three proteins (WT SWMb, MbH93Y, and HEC) are 
compared with their respective cyanide-ligated forms, the following differences in bond 
lengths were revealed: WT SWM[b and WT SWMb-CN differed in their Fe-distal 
ligand and average Fe-NP bond lengths; MbH93Y and MbH93Y-CN differed in their 
proximal Fe-O and average Fe-NP bond lengths; and HEC and HEC-CN differed in 
their Fe-distal ligand and proximal Fe-O bond lengths. 
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Reactions of Myoglobins wiith H2O2• The huge difference in the structure of the 
active sites of HEC and MbH93Y should lead us to dismiss the possibility that the 
corresponding different functions between HEC and SWMb are due solely to the 
different proximal ligand at the distal site. It was tempting to speculate that as a result 
of this mutation, Compound I (Fita and Rossmann, 1985) could not be formed and that 
this protein is incapable of any ca1talytic activity. Unlike HEC, MbH93Y was neither 
able to form a Compound I-like species nor was it able to decompose lfi0 2• And 
unlike the native SWMb (Powers et al., 1987) which formed a Compound II-like 
spectrum (Figure 10a), upon addition of 2.00 or 0.25 molar equivalents of lfi0 2, 
MbH93Y did not form myoglobin peroxide. After 8 minutes of exposure to lfi0 2, 
haemochromagen assay revealed the heme in native SWMb to be completely degraded 
(Figure 10b; Kellin and Hartree, 1950). Regeneration of the Soret peak upon treatment 
of SWMb by L-( + )-ascorbic acid following exposure to lfi0 2 indicated that the heme 
could be restored before the peroxide had time to completely oxidize the heme (Figure 
10c). On the other hand, following exposure to Ifi02, the heme in MbH93Y [Fe2+-Fe3+ 
couple, E 0 '= -190 mV (Adachi et al., 1991)] was not reducible by a small amount of 
ascorbate (Figure 10d), but was reducible by a small amount of sodium dithionite 
(Figure 1 Oe; recall absorption spec1ra, Figure 8). Haemochromagen assay revealed the 
presence of degraded hemes when ascorbate was the reductant (Figure 10d), but intact 
hemes were indicated when dithionite was the reductant (Figure lOe). Perhaps because 
Fe2+ -Fe3+ couple of E0 ' MbH93y= -190 m V and because dithionite is a stronger reductant 
Figure 10: Optical absorption spectra of the effects of exposure 
of native sperm whale myoglobin or MbH93Y to 2 molar equivalents of 
~0 2• Spectra are identical whether 2 or 0.25 molar equivalents were 
used. All reactions were c~xecuted in 20 mM phosphate buffer, pH 7 .0, 
at 25°C. (a) Minute-by-minute decay of the Soret band of native SWMb 
upon exposure to 2 molar equivalents ~0 2 where [native SWMb] = 7.25 µM 
and [HzOJ = 14.5 µM. (b) Haemochromagen assay reveals the presence of 
broken hemes after prolonged exposure to 0.25 molar equivalents ~0 2 
where [native SWMb] = 13.37 µM and [HzOJ = 3.34 µM. (c) Regeneration 
of the Soret band of the native protein is evident with the addition of 
a small amount of L-( + )-alScorbic acid, following exposure to 0.25 molar 
equivalents Hz02 (4.62 µ1'.1), where [native SWMb] = 18.5 µM. (d) Absorption 
spectra of the effects of exposure of MbH93Y to 0.25 molar equivalents Hz02 
with respect to the protein. All reactions were executed in 20 mM phosphate 
buffer, pH 7 .0, at 25°C. Exposure to 0.25 molar equivalents Hz02, followed 
by a small amount of L-(+ )-ascorbic acid, which was unable to restore the Soret 
peak. Haemochromagen assay revealed the presence of broken hemes. 
(e) Same conditions as in (d), except that sodium dithionite was the 


















































Figure 10 (Continued) 


























than ascorbate, dithionite is able to reduce the MbH93Y heme, electronically protecting 
the heme system from the damaging oxidative effects of ~0 2• Since ascorbate is not 
sufficient to reduce the MbH93Y heme, the prosthetic group is not protected from the 
damaging oxidative effects of ~0 2• 
In addition, an attempt was made to determine the ferric-ferry! (Fe3+-Fe4+) redox 
couple of MbH93Y in the same manner that Adachi et al. (1991) used for the ferrous-
ferric (Fe2+-Fe3+) redox couple of the human MbH93Y. In metmyoglobin, when H20 2 
oxidizes the porphyrin, a red-shift of the Soret band is observed, yielding a Compound 
IT-like (myoglobin peroxide) spec1rnm. However, when MbH93Y was exposed to a 
16-fold molar excess of potassium irridate or a 33-fold molar excess of ethyl hydrogen 
peroxide, no such red-shift resulted (Figure 11). These results indicate that in 
Figure 11: Results of the studies to determine the Fe~-Fe4+ redox 
couple of MbH93Y. In all experiments below, the [MbH93Y] = 6 µM. 
(a) Experiment in which a 3.33-fold molar excess, followed by a 
15.15-fold molar excess of the oxidant, potassium hexachloroirridate, 
was added to MbH93Y. Note the absence of any shift of the Soret band. 
(b) Experiment in which a 15.15-fold molar excess of potassium 
hexachloroirridate (relative to MbH93Y) was added to MbH93Y, followed 
by a 32.36-fold molar c~xcess of ethyl ~0 2• Again, note the absence 
of any spectral change. (c) For the sake of clarity, the spectrum of 
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MbH93Y, either the ferryl intermediate is unstable or the redox potential for the Fe3+-
Fe4+ is too high (> 1 V) to be determined in this manner. 
Cyanide Binding to Myoglobins. The binding affinity and kinetics of CN· to 
native 2(and/or WT) SWMb and MbH93Y were calculated from the titration of each 
protein with increasing concentrations of KCN, whose resultant reactions were 
followed spectroscopically (Figw,e 12) over time. A comparison of the CN· binding 
affinity and kinetics of the native (and/or WT) SWMb and MbH93Y reveals striking 
differences between the two proteins. Table 9 shows an average difference of 
approximately three orders of magnitude in binding affinity (Ko) between MbH93Y 
and the WT protein; that is, the latter binds CN· in the micromolar range (Ver Ploeg 
et al., 1971; King et al., 1992) while MbH93Y requires millimolar concentrations of 
CN·. Specifically, at the lower pH values of 5.5 and 6.0, there was a -H>2-fold 
difference between the native pmtein and the mutant; at pH 6.5, 7.0, and 7.5, this 
difference increased to three orders of magnitude; and at pH 8.0, there was -Ht-fold 
difference in K0 between the native protein and MbH93Y. Specific pH-dependent 
differences in Ko between the MbH93Y and WT SWMb were not identical, but 
comparable (Table 9). In addition, unlike the native or WT proteins, which always 
reached 100% saturation in forma1tion of the MbCN complex, MbH93Y reached only 
44-86% saturation, depending on the pH. 
Provided in Table 10 and Figure 13 are the graphically calculated apparent 
pseudo-first order rate constants C~t<app>) for CN· binding (Vega-Catalan et al., 1986) 
to the native and mutant myoglobiins. The native SWMb displays approximately the 
Figure 12: Typical optical absorption scans of the titration of (a) wild-type 
sperm whale myoglobin and (b) MbH93Y with increasing concentrations of KCN at 
pH 7.0. With the addition of each aliquot of known amount of KCN, the reaction 
was followed spectroscopically at the Soret wavelength until the reaction was 
complete. The spectrum at the resultant Soret wavelength and its corresponding 
absorbance were then recorded. The difference in absorbance (M) was then used 
in the calculations (Recall Chapter II, Experimental Procedures). The titration 
experiments were performed at pH values of 5.5, 6.0, 6.5, 7.0, 7.5, and 8.0; but 
since the calculations and resultant binding affinities and kinetics depend only 
on the M and on the relative concentrations of total myoglobin and total cyanide 
and are not visually revealed in the titration spectra of each experiment at each 
pH, the spectra at pH 7 .0 were chosen to illustrate a sample of a typical absorption 
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Table 9: Dissociation Constants (K0 , M) and Corresponding Changes in Free Energy 
(-~G, kcal moJ-1) for Native and Wild-Type Sperm Whale Myoglobin and MbH93Y at 
pH Values of 5.5, 6.0, 6.5, 7.0, 7.5, and 8.0. The SEM = Standard Error of the Mean. 
pH 5.5 6.0 6.5 7.0 7.5 8.0 
Native Ko 
SWMb X 10·5 2.44 2.08 0.570 0.451 0.240 0.522 
±SEM 0.329 0.866 0.001 0.154 0.110 0.394 
-t.G 6.25 6.35 7.11 7.25 7.62 7.16 
WT Ko 
SWMb X 10·5 3.00 1.56 1.43 0.439 0.346 0.281 
±SEM 0.239 1.32 0.152 0.101 0.103 0.205 
-t.G 6.13 6.52 6.57 7.26 7.41 7.53 
H93Y Ko 
X 10·3 6.19 3.96 5.43 8.55 8.18 11.7 
±SEM 2.37 0.0775 0.716 4.58 3.30 1.54 
-~G 2.99 3.26 3.07 2.80 2.83 2.62 
same pH-dependent trend of k+.l(app) for CN· binding reported earlier (Ver Ploeg and 
Alberty, 1968, 1971; Vega-Catalan et al., 1986; Ikeda-Saito et al., 1992). The 
MbH93Y, however, also displays a kinetic dependence on pH, but only at the extreme 
values examined. The pH-optima for the rate of CN· association appears to be at pH 
5.5, or, at least, below pH 6.0 (Table 10, Figure 13). We were unable to accurately 
evaluate the rate constant for CN· dissociation (k_1<•PP>) from either native (or WT) or 
MbH93Y due to the large degree of uncertainty associated with the intercept (Vega-
Catalan et al., 1986). This indicates that the reaction is not easily reversible and goes 
nearly to completion (Ver Ploeg and Alberty, 1968). Furthermore, unlike the native 
protein, which displays classic pseudo first-order kinetics, the rate of CN· binding to 
MbH93Y was biphasic at all pH values examined. Only the rapid phase is reported 
pH 
Table 10: Apparent Pseudo-First Order Rate Constants Ck+ic >• M"1sec·1) 
for Wild-Type Sperm Whale Mettnyoglobin and MbH93Y ;;:' pH Values of 
5.5, 6.0, 6.5, 7.0, 7.5, and 8.0. 
5.5 6.0 6.5 7.0 7.5 8.0 
wr 45.23 76.14 72.16 94.16 73.34 145.59 
MbH93Y 22.04 6.64 5.02 4.19 5.26 1.76 
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in Figure 13 and is still many orders of magnitude lower than that of the WT form. 
Cyanogen Bromide-Modified Myoglobins. Figure 14 displays the UV/visible 
absorption spectra of the reactio1t1 of CNBr with native SWMb (Figure 14a) and 
MbH93Y (Figure 14b). Modificadon of the distal His in the native protein is clearly 
evident by the dramatic blue shift of the Soret peak, indicating conversion from 
hexacoordination to pentacoordination (see below; Figure 14a; Jajczay, 1970) and by 
the fact that subsequent addition of 1½02 to the reaction leads to a dramatic decrease 
in the rate at which the Soret peak decreased, indicative of heme degredation (compare 
to Figure 10a). Modification of His64 in MbH93Y is also evidenced by a decrease in 
the rate of heme degredation by lfi0 2, but results in a Soret peak that is only very 
slightly red-shifted, indicating that the mutant protein was originally pentacoordinate 
before the introduction of CNBr. 
k+l (appl for CN" Binding 
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Figure 13: Time course decay curves for the reaction of native sperm whale 
myoglobin or MbH93Y with cyanide at the pH values of 5.5, 6.0, 6.5, 6.5, 7.0, 7.5, 
and 8.0. The decay curves were followed at the Soret peak A (Table 1) for each 
respective protein for 10 minutes to make sure the reaction was complete. 
Calculations of the pseudo-first order rate constants and apparent rate constants l:k+.icapp>• 
M·1sec·1, mean + standard error of the mean (SEM)] · of the bimolecular reaction of the 
WT SWMb or MbH93Y plus CN· were performed as described by Vega-Catalan et al. 
(1986), where the plots of ~ vs. [CN"] displayed linear correlation coefficients 
between 0.90-1.00. For the sake of clarity, the plot of the native SWMb is not shown. 
Experimental conditions were identical to those for determining the Ko's (Table 9), 
since both K0 and k+,l(app) can be calculated from the same experiment. From the 
current titration curve, due to only one sharply defined pH-optima (pH 5.5), only an 
approximation of the PK. could be made, which appears to be between 5.5 and 6.0. 
Figure 14: Optical absorption spectra of the reaction of cyanogen bromide modification of the distal histidine in native 
sperm whale myoglobin or MbH93Y. In Panel a, [SWMb] = 1.34 - 4.07 µMand in Panel b, [MbH93Y] = 1.44 - 3.22 µM. 
For either protein, [CNBr] = 615 - 645 µMand [H20;) = 1 - 2 µM. Panel a: (a) Unmodified native SWMb; (b) 7 minutes, 
35 seconds (7:35) after the addition of 615 µM CNBr; (c) Addition of 1.08 µM H20 2; (d) 3:30 after the addition of H20 2; 
(e) 7:00 after the addition of H20 2; (f) 15:00 after the addition ofH 20 2; (g) Addition of solid grains ofL-(+)-ascorbic acid. 
The rate of distal His modification by CNBr was calculated by following the decrease in the absorbance at 409 nm. 
Calculation of the observed pseudo-first order rate constant, Ic. = 1.326 x 10-2 ± 4.01 x 10·3 sec·1, was linear (Vega-Catalan 
et al., 1986) in a plot of absorbance changes over time; correlation coefficient, R = 1.00. Panel b: (a) Unmodified MbH93Y; 
(b) 4:20 after the addition of 645 µM CNBr; (c) Addition of 1.08 µM H20 2 at 10:37 after the addition of CNBr; (d) 3:23 
after the addition of H20 2; (e) Addition of solid grains of L-(+)-ascorbic acid 6:33 after the addition of H20 2• Obviously, 
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Moreover, the addition of Hz02 to the CNBr-modification reaction generates a 
sharp isosbestic point in the Soret peak in SWMb (Figure 14a), which strongly 
indicates that the metaquo SWMb is being converted from a hexacoordinate to a 
pentacoordinate species. On the other hand, the lack of Soret peak shift and the 
absence of an isosbestic point in the CNBr-modified MbH93Y reaction, following the 
addition of Hz02, clearly indicate ~rfi>H93Y was already pentacoordinate, in agreement 
with the XAS results. 
Acid+-+Alkaline Transitions of Myoglobins. Shown in Figure 15 are the 
acid+-+alkaline transition curves of the native and ~H93Y proteins. Consistent with 
previously reported values for native SWMb, the PK. of the acid• alkaline transition 
and that of the alkaline • acid transition was found to be 8.9 (Figure 15a; Ham.ell et 
al., 1968; Shire et al., 1974a, b; Mlorishima et al., 1978; Yamazaki et al., 1978) and 
6.5 (Yama7-ald et al., 1978), respectively. However, while the alkaline • acid transition 
for the mutant protein yielded a pKi1 of 6.5 (Figure 15e), the PK. of the acid• alkaline 
profile yielded a value of ca. 12.0 (Figure 15c). The stability constants for the 
formation of the hydroxyl complexc:s for native SWMb and ~H93Y were calculated 
to be 5.1 and 2.0, respectively. However, while native SWMb yielded the typical Hill 
Plot of n -1.00 (Figure 15a), ~H93Y exhibited a Hill Plot that was biphasic in nature 
(Figure 15c,e), suggesting that some sort of general heme-linked protonation coupled 
with some degree of protein denaruration occurs. 
Figure 15: Forward and reverse titration curves of native sperm whale 
myoglobin and MbH93Y. The forward and reverse titrations were executed with 
increasing concentrations of NaOH and HCl, respectively, of (a) 3-4 µM native 
SWMb starting at pH 6.54 and (b) at pH 8.03. In (a), the inset reveals a Hill 
Plot with a slope of n - 1.00. (c) 2-4 µM MbH93Y starting at pH 8.15, titrating 
through to pH 12.72, and then back to pH 7.1, all within the same reaction cuvette. 
(d) Back-titration of MbH93Y starting at pH 12.8. (e) Back-titration of MbH93Y 
starting at pH 12.73 and continuing through to pH 5.67; only the acidic side of the 
curve is shown since the basic side is identical to that shown in (d). Back-titration 
of MbH93Y starting at pH 9.38 and continuing through to pH 5.41 is also identical to 
the curve displayed in (e) (Data not shown). In (e), the inset reveals a biphasic Hill 
Plot. See text for explanation. 
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Figure 15 (Continued) 
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Spectroscopy. We used optical absorption and XAS spectroscopies to probe the 
active sites of MbH93Y, WT SWMb, and HEC and compared the mutant protein to 
the two controls. In the optical absorption spectra, a blue-shift of the Soret peak from 
409 nm (WT) to 403 nm (Figµre 8, ·Table 1) for MbH93Y strongly suggests 
pentacoordination and reflects the fact that the phenolic oxygen fifth ligand possesses 
more negative charge than the imidazole WT fifth ligand. This fifth ligand phenolic 
oxygen exhibits a trans effect through the heme Fe, enabling it to repel a ligand (e.g., 
an oxygen atom of a water molecule) from binding to the sixth position on the distal 
side of the heme. Our XAS results, which are shown in Figure 16, also show a 
pentacoordinate heme in MbH93Y. Furthermore, the proximal bond length in WT 
SWMb did not change as a result c,f the mutation, which is significantly different from 
that of HEC. That is, simply replacing the fifth ligand with a Tyr does not alter the 
bond distances in the active site. However, the negative charge density of the phenolic 
oxygen atom results in an electrostatic repulsion of water through the Fe bond and 
pentacoordination. 
Normally, at the low temperatures (~ -130 - -100°C} at which XAS data are 
recorded (Powers, 1982), met SWMb (Chance et al., 1986b) and catalase (Chance et 
al., 1984) are indeed liganded at th.e distal site. In the crystal structure of bovine liver 
catalase (23°C}, however, the sixth-coordination site is vacant (Murthy et al., 1981), 
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Figure 16: EXAFS-derived bond distances of the active sites of wild-type 
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sperm whale myoglobin, MbH93Y, horse erythrocyte catalase, and of their respective 
cyanide-ligated complexes. Distances are in angstroms and the errors are provided in 
the text 
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al., 1988; Sharma et al., 1989). However, other peroxidases are known to become 
hexacoorclinate at low temperatwres such as lactoperoxidase (Manthey et al., 1986), 
cytochrome c peroxidase (Smulevich et al., 1991) and lignin peroxidase (Sinclair et al., 
1992). 
The hemoglobin mutant, Iwate (mutation of the proximal His • Tyron the ex 
chains of hemoglobin), is also pentacoorclinate (Nagai et al., 1983) and binds 0 2 poorly 
(Greer, 1971), as does MbH93Y. Similarly, in my hands, the oxy-form of MbH93Y 
was impossible to achieve (Table 1), indicating that simple ligand binding at the distal 
site is influenced by the identity of the proximal axial ligand (Goldsby et al., 1986). 
The average Fe-to-pyrrole nitrogen (Fe-NP) bond lengths of MbH93Y-CN were 
signficantly different (outside the error) from that of either met SWMb-CN or HEC-
CN. However, unlike the met fomis, where the MbH93Yproximal bond is longer than 
that in HEC, the proximal bond length of the MbH93Y-CN is shorter than that of 
HEC-CN. 
Comparison between each protein and its respective cyanide-ligated form revealed 
that WT SWMb and its cyanide-ligated form were significantly different in their Fe-NP 
and distal bond lengths (although this difference is close to the total error), MbH93Y 
and its cyanide-ligated form were significantly different in their Fe-NP and proximal 
bond lengths, and HEC and HEC-CN were significantly different in both axial bond 
lengths. When CN· binds the Pe3+ in MbH93Y, there is considerable 1t-electron 
withdrawal through the Fe to the CN· ligand. This results in electron withdrawal from 
the 1t-orbitals of the heme system, pulling the phenolate ligand inward, shortening the 
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proximal bond, as well as the Fe-NP bonds, pulling the Fe into the plane of the heme 
and culminating in a low-spin complex. Alternatively, the distal His, as a result of the 
proximal mutation, may not be as free to swing as in the WT protein. If the distal His 
is able to form an H-bond with the nitrogen of the bound CN-, some of the electron 
density of the antibonding 1t* orbitals of the cN- will be drawn away from the Fe 
bond. This is consistent with the determination of the greatly increased pK. of -12.0 
(Figure 15c). 
Oxidation of Myoglobins by li 20 2• In order to test the functional consequences of 
this single His-to-Tyr mutation, it was necessary to determine if the MbH93Y can form 
a Compound I-type intermediate, functionally different from myoglobin peroxide 
(George and Irvine, 1952, 1953, 1956), but similar to that formed by catalases and 
peroxidases . As established earlier by resonance Raman spectroscopy (Morikis et al., 
1990) and our studies at low and room temperatures (Figure 16), the most striking 
difference between the MbH93Y imd WT SWMb or HEC is the absence of a distal 
ligand in the mutant protein (see Frauenhoff and Scott, 1992). The proximal Tyr 
lowers the Fe2+-Fe3+ redox potential by ~135 mV in human myoglobin (Adachi et al., 
1991) compared to WT human myoglobin. In terms of active site structure, probably 
the most important property responsible for the high degree of activity found in HEC 
is the complex H-bonding network on the proximal side (Fita and Rossmann, 1985). 
This highly polar environment, in addition to the short Fe-O bond length of 1.90 A 
(Figure 16; Murthy et al., 1981; Chance et al., 1984) and the localized negative charge 
on the deprotonated phenolic oxygcm (Fita and Rossmann, 1985), probably contributes 
60 
to the extremely low redox potential of this enzyme [E0 ' < -500 mV (Adachi et al., 
1991)]. In MbH93Y, whose proximal bond length is unchanged as a result of the 
mutation and still is significantly longer than that in HEC (Figure 16), the through-Fe 
bond trans effect towards the distal side is much weaker compared to that in HEC, but 
stronger than that in WT SWMb. In addition, the active site pocket of myoglobin is 
much less polar (Poulos, 1988) than that of HEC, so MbH93Y is less capable of 
forming an appreciable H-bonding network on the proximal side like that in catalase 
(Fita and Rossmann, 1985). Obviously, since WT SWMb does not have this through-
Fe trans electrostatic repulsion, this protein is much better able to accommodate a 
ligand bound at the distal site. Because one edge of the heme in WT SWMb and in 
MbH93Y is exposed to the solvent (Takano, 1977), the prosthetic group in these 
proteins is more susceptible to oxidation by HiO2• However, in WT SWMb, whose 
distal site is occupied by HiO, the heme is much more sterically protected (e.g., 
Guillard et al., 1991) from 1-IzO2 (Tetreau et al., 1990; McArthur and Davies, 1993) 
than is the mutant protein. Prolonged exposure of WT SWMb to 1-IzO2 (over an 8-
minute period) resulted in a Compound II-like spectrum (Figure 10a). At shorter 
times, ascorbate was able to reduce the Fe and restore the Soret peak (Figure 10c). 
However, the vacancy of the distal site in the MbH93Y left the heme open to oxidative 
attack by H2O2• The maximum absorbance of the Soret peak plummetted within less 
than 1 minute and was not retrievable by reduction with ascorbate (Figure 10d). 
Dithionite red-shifted the Soret peak 20 nm (Figure lOe), 7 nm shorter than normally 
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produced with this reductant (cf. Figure 8, Table 1) and was unable to restore the Soret 
peak. 
Furthermore, because the subs1titution of a Tyr for a His in the heme pocket is not 
isosteric (Creighton, 1984), it is possible that in addition to the trans electronic 
repulsive effects of the phenolate oxygen, there is also a heme pocket rearrangement, 
both of which may contribute to favoring fifth-coordination in MbH93Y. Indeed, this 
substitution may disrupt the H-bonding network among the hydroxyl of Ser92, N~ of 
His93, one of the two propionate groups, His97 and Leu89 on the proximal side 
(Biram et al., 1993; Smerdon et al., 1993). Although it is possible that the phenolic 
oxygen atom can form a H-bonding network on the proximal side as it does in catalase 
(Fita and Rossmann, 1985), it is unlikely that Tyr93 would have the same H-bonding 
constraints of the Wf His93 residue. The proximal ligand, Tyr93, may now be more 
free to move about, compared to \VT His93, possibly culminating in a more exposed 
heme (Smerdon et al., 1993) and greatly enhancing the susceptibility of the heme to 
oxidation by Hz0 2• 
When a heme protein (e.g., catalase, cytochrome c peroxidase) is exposed to Hz02, 
0 2 is evolved. Indeed, many inves1igators routinely use 0 2 evolution as a measure of 
dismutation activity (e.g., Adachi et al., 1993). However, the globins differ from the 
peroxidases and catalases inasmuch as the number of reaction cycles with Hz02 
completed by the globins is severely limited (ca. 8, King and Winfield, 1963; Tajima 
and Shikama, 1993). Also, these proteins are altered in the reaction as well (King and 
Winfield, 1963). When Wf SWI~b was exposed to Hz02, there was not only a 
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gradual drop in the maximum absorbance of the Soret peak, but also a slight red-shift 
yielding a Compound II-like spe<;trum (Figure 10a; King and Winfield, 1963), which 
is indicative of a ferryl intermediate, similar to that of catalase (Nicholls and 
Schonbaum, 1963). After 10-15 minutes, haemochromagen assay revealed broken 
hemes, indicating complete oxidation by Hz02 (Figure 10b; Kellin and Hartree, 1950). 
However, if reductant was added early in the reaction, the Soret peak was restored 
(Figure 10c). 
On the other hand, when MbH93Y was exposed to Hz02, there was a rapid, 
drastic, and irreversible loss of th.e Soret peak (Figure 10d; also Adachi et al., 1993), 
which may be due to a sterically accessible heme via the vacancy at the distal site 
(Figure 16) and/or disruption of the H-bonding network on the proximal side. In WT 
SWMb, it has been suggested that the ferryl state is governed by the accessibility of 
H20 in the pocket, bound at the distal site (Whitbum, 1987). In addition, unlike in 
WT SWMb, it is possible that the strong electron-donating phenolate ligand in 
MbH93Y does not allow production of a porphyrin 7t cation radical/FeIV =O complex 
(Dounce and Sichak, 1988). The absence of this cation radical could result in a 
destabilization of the the FeIV=O intermediate (Yamazaki and Nakajima, 1988), 
possibly resulting in a net negative charge in the immediate vicinity of the Fe, 
increasing the overall negative charge density in the heme, and ultimately disrupting 
the 1t-conjugated system. 
Binding by Cyanide. Like BLC (Fita and Rossmann, 1985) and the hemoglobin 
mutants, Hyde Park (mutation of the proximal His • Tyr in the ~ chains of 
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hemoglobin; Greer, 1971) and Iwate (mutation of the proximal His • Tyr in the ex 
chains of hemoglobin; Nagai et al., 1983, 1989), MbH93Y is also high-spin. As in the 
reactions with H20 2 discussed above, the strong electron-donating effects of the 
phenolate ligand (a weak field ligand) can prevent CN· from binding at the distal site 
in MbH93Y and are manifested by an affinity constant, which average three orders of 
magnitude higher than those for VvT S~b (Table 9). This result is further reflected 
by the inability of the mutant to achieve 100% saturation or formation of the metcyano 
complex. When CN" approaches, the Fe in MbH93Y undergoes o-electron donation 
from the proximal side and 1t-electron withdrawal from the distal side, leading to a 
repulsion of the incoming CN· ligand and a resulting lower affinity, compared to the 
native or VvT SWMb. Native (and VvT) SWMb also has the ability to repel CN· by 
the same mechanism; however, imidazole(ate) is a stronger field or electron-
withdrawing ligand than phenolate, but is weaker than CN·. The 1t-acid ligand, 
therefore, is able to complement the field strength of the imidazole, both ultimately 
contributing to the low-spin state of the heme. Our XAS shows that upon CN· binding 
to the mutant, both the proximal lligand bond and the Fe-NP bond distances shorten 
(Figure 16), which are results consistent with the 1t-withdrawal from the distal site. 
Furthermore, in native SWMb,. Ver Ploeg et al. (1971) proposed that CN" attacks 
the distal site via a dissociation-asssociation mechanism, with H20 leaving before CN· 
binds. Both native and VvT SWMb, perhaps due to the occupied distal site, take up 
to 10 minutes to reach equilibrium upon binding CN·. In MbH93Y, however, there is 
no leaving group to dissociate before CN· binds. 
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Biphasic kinetics of CN· binding to MbH93Y is exhibited at all pH values 
examined. There is a rapid phase::, which is completed within 10-15 seconds. A slow 
phase follows, probably due to some conformational change within the heme pocket, 
which reaches equilibrium within 5 minutes and is reminiscent of the slow phase of 
a conversion of reduced, low-spin cyano-lactoperoxidase to a high-spin cyano complex 
(Manthey et al., 1986). The rapid phase is still many orders of magnitude slower that 
the pseudo first-order kinetics displayed by the WT protein (Table 10; Ikeda-Saito et 
al., 1992) and is consistent with the observation of approximately three orders of 
magnitude more cN· required to ireach equilibrium with the mutant protein than with 
WT. 
pH Effects. The pH dependence of the kinetics of CN· binding and dissociation 
has been the focus of a number of studies utilizing site-directed mutations in the distal 
pocket (Bellelli et al., 1990a; Ikeda-Saito et al., 1992). However, in our study of the 
proximal mutation, we observed a simple bimolecular reaction where Mb++ CN· H 
MbCN and K0 = k-ifk+1 (Vega-Catalan et al., 1986), where the forward rate constant, 
k..icapp>• and K0 both differ significantally between the native (or WT) SWMb and 
MbH93Y. As discussed in Chapter ill, we were unable to accurately calculate the rate 
of the dissociation, the k_1capp>• However, in the presence of dithionite, Bellelli et al. 
(1990a) detected an unstable, transient intermediate, whose rate of decomposition to 
the unligated SWMb was inversely proportional to pH. These investigators tested two 
different point mutations of the distal His, substituted by a Gly or a Val residue, which 
exhibited large decreases in the ra1te of the decomposition reaction at acidic pH. Thus, 
65 
our study of the rate of the forwaird binding reaction and that of Bellelli et al. (1990a) 
of the rate of the dissociation reaction both show a pH dependence at acidic pH. 
In my study, the failure to observe any significant dependence on pH, of K0 or 
the k+.icapp>• with the mutant protein except between the extreme pH values examined 
may have been due to the buffer effects of 0.1 M ionic strength MES/MOPS. It has 
long been known that the type and strength of the buffer influences the behavior of 
native SWMb (Ver Ploeg and Alberty, 1968; Ver Ploeg et al., 1971). Although both 
MES and MOPS are Good's buffers, an appropriate study to undertake in the future 
would be to characterize MbH93Y under a wide variety of buffers, ionic strenghs and 
pH values, perhaps in smaller intervals than at every half-unit as was performed in this 
study (Ver Ploeg and Alberty, 1968; Ver Ploeg et al., 1971). Nevertheless, the 
observed differences in k+.icapp> at pH 5.5 and 8.0 lend support to our earlier results of 
enhanced negative charge density trans to the phenolate oxygen. At pH 8.0, CN· anion 
has over 300 times more OH· ions with which to compete than at pH 5.5. And since 
OH" is a much weaker field ligand than CN·, the observation of a higher rate of 
association and lower dissociation 1constant at the lower pH is not at all surprising. At 
pH 5.5, the [H+] is over 300 times higher than at pH 8.0, thereby protonating the distal 
His, which swings out of the way (Ramsden and Spiro, 1989) and facilitates CN· 
binding. 
Cyanogen Bromide Modification of Myoglobins. Sterle modification of the 
distal His by CNBr has been demonstrated to be an effective means to probe the 
dynamics of ligand binding in the distal pocket of heme proteins (Jajczay, 1970; 
66 
Morishima et al., 1989; Bracete et al., 1991). Specifically, the imidazolyl N-H of 
His64 in SWMb is substituted by a N-CN moity (Morishima et al., 1989 and 
references cited therein), thereby disrupting any potential for the distal His to form a 
H-bond with a ligand (Phillips and Schoenborn, 1981). Although the heme has been 
converted from six-coordinate to five-coordinate, indicated by the prominant blue-shift 
of the Soret and the isosbestic point upon exposure to HzO2 (Figure 14a), the heme is 
now more protected from the damaging, oxidative effects of H2O2 than in unmodified 
hexacoordinate SWMb. This oxidative reaction by HzO2, manifested by a rapid, 
irreversible loss of the Soret peak seen in Figure 10a, is much slower in the CNBr-
modified SWMb. This could occ:ur by one or both of the following mechanisms: (i) 
the binding of CNBr to the distal His prevents this residue from swinging down in its 
usual gate-like fashion, which provides large ligand entry into the pocket (Johnson et 
al., 1989); or (ii) modification of the histidyl imidazolyl NH to N-CN could sterically 
constrain this residue, thus preventing H-bonding to incoming ligands, including HzO 
(and H2OJ, at the distal side (Phillips and Schoenborn, 1981; Morishima et al., 1989). 
In other words, CNBr binding to His64 could prevent this residue from swinging out 
of the way as quickly as it would in unmodified SWMb, thereby delaying, but not 
completely preventing, H2O2 from damaging the heme. 
Cyanogen bromide modifi1cation of His64 in MbH93Y resulted in the same 
decrease in the rate of heme degre:dation by lizO2 (Figure 14b), relative to unmodified 
MbH93Y (Figure lOe). Equally important, this finding corroborates the optical 
absorption and XAS results of a vacancy at the distal site in MbH93Y (Figure 16) and 
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lends credence to the phenomenon of the strong, through-Fe, electron-donating effects 
of the phenolate oxygen. That is, the strong, trans-labilizing effects of the phenolate 
oxygen will serve to help neutralize the positive charge on the Fe, thereby decreasing 
the residence time (Schonbaum, 1982) and affinity of a ligand, e.g., HzO, CN·, at the 
distal site. Cyanogen bromide substitution of a N-CN on the distal imidazolyl can 
only help maintain or reinforce th,e five-coordinate structure of this protein via one or 
both of the steric mechanisms discussed above for the native protein and is manifested 
by the absence of any significant shift of the Soret band (Figure 14a). 
AcidHA/kaline Transitions of Myog/obins. Like the peroxidation and the CN·-
binding profiles, the acidHalkaline transition for MbH93Y is also drastically different 
from that of the native SWMb. The ionization constant of 8.9 for native SWMb has 
been cited as the midpoint potential of the protolytic exchange of a Ir between an Fe-
bound OH ligand and the distal imidazole in metMb (Morishima et al., 1978; 
Yamazaki et al., 1978). 
However, several surprises were revealed in the characterization of the 
acidHalkaline transition of the MbH93Y . In light of the three orders of magnitude 
difference in the basic PK. betwee:n the native protein and MbH93Y, it is surprising 
that there was no difference in the acidic PK. for H+ dissociation between the native 
SWMb and mutant protein. The shape of the forward titration (acid• alkaline) curve 
for MbH93Y indicated a pH-dependence much more complex than that for the native 
protein. Unlike the reverse titration for native SWMb, the alkaline• acid titration for 
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MbH93Y was not reversible and the Hill Equation yielded a curve that was biphasic 
over the pH range 9-12. 
Importantly, the drastically increased PK. of MbH93Y (-12.0) relative to native 
SWMb (8.9) in the relatively nonpolar active site is expected, due to the through-Fe 
negative charge density imposed by the phenolate oxygen atom. Specifically, the 
charge neutralization of the Fe3+ inhibits deprotonation and gives rise to the observed 
increased PK. of the distal His. The active sites of catalase and SWMb are drastically 
different in polarity. However, they share the common feature of the fifth ligand in 
MbH93Y. Due to the polarity of the respective active sites, the PK. of the distal His 
in catalase, which is oriented roughly parallel (Fita and Rossmann, 1985) instead of 
perpendicular to the heme as in SWMb, is expected to decrease (Fita and Rossmann, 
1985) relative to free His in solution. 
In addition, the increased pK, of 12.0 for MbH93Y relative to the native SWMb 
means that more than three orders of magnitude in the concentration of OH ions are 
required to titrate MbH93Y and would be consistent with a population of protonated 
distal imidazoles 3-fold higher than those which are not protonated. Such protonation 
of the distal His represents removal of a major steric barrier to ligand binding 
(Ramsden and Spiro, 1989). 
The fact that the pK.'s of both proteins are virtually identical on the acid side 
(Figure 15b, e), but so different 01r1 the alkaline side (Figure 15a, c), strongly indicates 
that in MbH93Y, unlike the native protein, simple association/dissociation reactions 
are not taking place between Wand OH· ions. More likely, MbH93Y is undergoing 
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some sort of electrostatically imposed local or global conformational change--a change 
perhaps similar to the binding of larger ligands by native SWMb (Johnson et al., 
1989). Such a change is supporte:d by the biphasic nature of the Hill plot between pH 
9-12. Overall, the Hill constant was n = 1.50, but inspection of the inset of Figure 15e 
clearly indicates that such a calculation is erroneous as are any conclusions about 
cooperative effects. Rather, the biphasic nature of the Hill Plot of MbH93Y (Figure 
15e, inset), as well as the irreversibility of the forward and reverse titrations (Figure 
15c), probably represents some combination of general heme-linked protonation and/or 
proton dissociation and protein de:naturation. Again, just as in the case of CN· binding, 
an appropriate study to undertake next would be to examine the behavior of MbH93Y 
in the presence of various buftiers and differing ionic strengths similar to those 
performed on native SWMb (Veir Ploeg and Alberty, 1968; Ver Ploeg et al., 1971; 
Shire et al., 1974a, b; Janssen et al., 1972). 
Inspection of Figure 15e of the forward and reverse titrations of MbH93Y 
executed in the same sample reveals that the mutant is probably not as stable as the 
native form. That is, the failure of the reverse titration curve towards the acidic side 
to follow the same route as that of the forward titration towards the basic side indicates 
that some denaturation of the protc::in may have occurred. Such denaturation would be 
accurately represented by the difference between the two curves. Therefore, it appears 
that unlike native SWMb, which (ii) titrates reversibly between pH 5-10 (Antonini and 
Brunori, 1971), (ii) is stable even at pH 12.9 (Uyeda and Peisach, 1981), (iii) has its 
Fe-His bond able to withstand an environment of pH 4.0, and (iv) maintains its 
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integrity even at pH 2.6 in the CO-ligated form (Sage et al., 1991a, b; 1992), the 
conformational changes MbH93Y undergoes could ultimately culminate in partial or 
complete unfolding, eventually leading to denaturation. This indicates that the mutant 
is not as stable as its WT counu:rpart. Such pH-associated conformational changes 
have been extensively studied (Shimada and Caughey, 1982; Yang and Honig, 1993) 
and in the case of myoglobins, do not n~essarily all involve deprotonation of a distal 
H2O molecule (Morishima et al., 1978; Yamazaki et al., 1978), but perhaps may 
involve some residue near the Fe (Giacometti et al., 1975). 
Recently, Biram et al. (1993) mutated the Ser92 to a Leu residue on the proximal 
side in pig metMb and found an increased affinity for both N3• (Biram et al., 1993; 
Smerdon et al., 1993) and OH rellative to the WT protein. Importantly, this mutation 
of the Ser to a Leu disrupts the H-bonding network on the proximal side, allowing 
His93 greater freedom to rotate laterally as well as to move towards the Fe (Biram et 
al., 1993). Thus, by removing some of the steric constraints on the proximal side, 
Biram et al. (1993) were able to decrease the pK. of the distal His in the S92L mutant 
relative to WT. In striking contrast, in our MbH93Y mutation, the huge increase in 
pK., reflected by a 2.5-fold lower formation constant relative to native SWMb 
represents an electronic influence that (i) largely overshadows most steric 
considerations since the side chain of Tyr is only a little larger than that of His 
(Creighton, 1984) and (ii) is at the limiting PK. for a weak acid ligand as predicted by 
Schonbaum (1982). 
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Summary. All of the res:ults in this study can be explained in terms of the 
EXAFS-derived bond lengths, th,e steric and electronic implications for the mutation 
of a His to a Tyr residue, and the polarity or ionic environment of the surrounding 
active site. 
Compared with the respective bond distances in WT SWMb, both Fe-NP and the 
Fe-proximal ligand bond distances remained virtually unchanged. Compared to HEC, 
the Fe-NP distance is also about the same in MbH93Y, but the Fe-proximal ligand 
bond length is significantly shom~r in HEC. Strikingly, however, unlike WT SWMb 
and HEC, the distal site in MbH93Y is vacant. Compared to WT SWMb, the stronger 
through-Fe electrostatic repulsion of the phenolate oxygen atom in MbH93Y is most 
likely responsible for the vacan1cy at the distal site. However, MbH93Y, while 
possessing the same axial ligand as that in catalase, does not have the same complex 
H-bonding network present in HEC, which is considered to be responsible for the high 
catalytic/catalatic activity of this enzyme. In addition, compared to HEC, whose 
proximal bond length is significantly shorter than in either the WT or the mutant 
myoglobins, the longer Fe-Ne bond in the globins does not confer any true catalytic 
activity onto these proteins. The shorter proximal bond distance in HEC, compared 
to that of the globins, may also play a prominant role in the activity of this enzyme. 
Among the cyanide-ligated proteins, the proximal and the Fe-NP bonds of 
MbH93Y-CN are shorter than those of WT SWMb-CN. This is probably due to 
weaker cr-donor interaction and 7t !back-bonding of the phenolate in MbH93Y-CN and 
consequently less electronic overlap along the p7t orbital directions and shortening the 
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Fe-NP bonds relative to the proximal imidazole in the WT SWMb-CN. In HEC-CN 
and in WT SWMb-CN, despite the different proximal ligands and active site 
environments, the distal, Fe-Np, and proximal ligand distances were no different 
between the two cyanide-ligated proteins. The effect CN· has on each protein is to 
generate the low-spin state of the heme via electronic repulsion between the two axial 
ligands through the Fe, resulting in shorter Fe-NP bond lengths compared to their 
respective met forms. 
Unlike WT SWMb, MbH93Y was unable to form myoglobin peroxide. In fact, 
the heme in MbH93Y undergoes irreversible and much more rapid oxidation by 2-
molar equivalents of ffiO 2• These results may be explained in terms of an active site, 
which is much more highly exposc:d by the vacancy at the distal site and disruption of 
the H-bonding network on the proximal side. 
When HCN approaches the Fe, the metal in MbH93Y undergoes a-donation 
from both the proximal and distal sides, as well as 7t back-bonding from the Fe in both 
directions, but more strongly towards the phenolate ligand. This ultimately leads to 
an electrostatic repulsion of the incoming CN" ligand and results in lower rate 
constants and binding constants within the pH range between 5.5 and 8.0, compared 
to that of either native or WT SMlib. Again, the highly polar active site of HBC and 
its short Fe-proximal ligand bond distance enables this protein to delocalize the 
negative charge of the phenolate ligand, which allows CN· to bind tightly. 
Sterle modification of the distal His enabled us to probe the dynamics of the 
binding pocket, using the UV /visible absorption spectra of the reaction to 
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biochemically confirm the optical absorption and EXAFS results of a pentacoordinate 
heme in MbH93Y. 
Both the native and MbH93Y displayed the same acidic pK_'s of 6.5, while their 
basic pK_'s differed by more thain three orders of magnitude. The PK. of 12.0 for the 
mutant is again primarily attributed to the strong, through-Fe, negative charge density 
of the phenolate oxygen atom. hl addition, unlike native SWMb, the irreversibility of 
the forward and reverse titration curves in MbH93Y, as well as the peculiar shape of 
the curves, may indicate a local or more global conformational change in the globin. 
This apparent greater susceptibility to changes in the immediate ionic environment 
would be consistent with a more exposed heme, revealed by the spectroscopic studies, 
and the possible disruption of the: H-bond network on the proximal side. 
Conclusions. The mutation of the proximal His to a Tyr residue in SWMb is 
the logical first step for rational redesign of a heme protein. Following molecular 
dynamics simulations and energy minimization calculations, the next logical step(s) to 
undertake would be to mutate the heme pocket of SWMb in order to introduce a H-
bonding network in conjuction wiith the existing proximal mutation; such a H-bonding 
network would be designed by mutating certain key residues in SWMb that correspond 
to the homologous site or position that exists in catalase . The structural and 
biochemical consequences of these mutations could then be evaluated. The ability to 
form Compound I would be the prerequisite to the long-range goal of conferring onto 
SWMb the type, and if possible, 1the degree of enzymatic activity present in catalase 
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and CcP. To this end, the type of H-bonding seen in the active site of catalase could 
ideally be duplicated in that of SWMb. 
The current use of heme protieins in biosensors and clinical and biochemical assays 
and their potiential use in biomolecular electronics and the degredation of toxic wasties 
are only a few examples of their broad utility. Heme proteins are ideal candidates for 
use as biomolecular electronic matierials,. because of their unique electron transfer 
properties. Several investigators have been exploiting this potential in this respect 
using site-directed mutagenesis for general investigations of electron transfer and to 
improve monolayer formation in the production of a "protein chip" (Stayton et al., 
1989; Walker, 1991). For example, in biosensor applications, horseradish peroxidase 
has long been used as part of the: assay for cholesterol; heme protieins have potential 
as intiegral parts of many biosensors (Ball et al., 1986; Hill, 1987). Two of the key 
problems in biosensor tiechnology have been specificity of the interaction of the probe 
with the molecule of interest and the stability of the probe. My studies presented in 
this work and the next logical steps of heme protiein rational redesign, such as the 
introduction of a H-bonding network, will ultimately increase our understanding of 
heme protein catalysis and facilitate these needed improvements . 
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